痛みの薬物治療

出版社： 文光堂
著者：
発行日： 2013-07-03
分野： 臨床医学：外科  >  麻酔科学/ペイン
ISBN： 9784830628344
電子書籍版： 2013-07-03 （第1版第2刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

14,300 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

14,300 円(税込)

購入する

商品紹介

痛みの薬物治療に必要な基礎的知見から各薬剤の作用機序，薬物動態，鎮痛効果の特徴などに加え，痛みの種類や痛みが生じる原因ごとの鎮痛薬の選択までをビジュアルに解説．

目次

  • 痛みの薬物治療

    ―目次―

    総説
    　痛み治療における薬物療法の位置づけ

    解説
    ?．総論
    　1 鎮痛薬の作用を理解するための解剖
    　2 鎮痛薬の作用を理解するための生理
    　3 鎮痛薬の作用を理解するための薬理
    　　　?主要な神経伝達物質とその受容体?
    　4 内臓痛のメカニズム
    　5 炎症痛のメカニズム
    　6 神経障害痛のメカニズム
    　7 作用の個体差
    II．高齢者・小児に対する薬の使い方
    　1 高齢者の痛みに対する薬物治療
    　2 小児の痛みに対する薬物治療
    III．鎮痛薬の投与経路
    　1 投与経路の特徴と適応
    IV．痛みのメカニズムとその対応
    　1 疝痛・鈍痛
    　2 アロディニア
    　3 電撃痛
    　4 しびれ
    　5 痒み
    V．痛みの治療に用いる薬物の特徴
    　1 麻薬系鎮痛薬
    　2 拮抗性鎮痛薬
    　3 トラマドール
    　4 非ステロイド性消炎鎮痛薬
    　5 アセトアミノフェン
    　6 ステロイド
    　7 ケタミン
    　8 ブチルスコポラミン
    　9 ノイロトロピン
    　10 ボツリヌス毒素タイプA
    　11 漢方薬?選択の参考所見
    　12 鎮痛補助薬

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

総説

P.5 掲載の参考文献
1) Torrance N, et al : The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 7 : 281-289, 2006
PubMed
2) Bouhassira D, et al : Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136 : 380-387, 2008
PubMed
3) 服部政治ほか : 日本における慢性疼痛を保有する患者に関する大規模調査. ペインクリニック 25 : 1541-1551, 2004
 
4) Nakamura M, et al : Prevalence and characteristics of chronic musculoskeletal pain in Japan. J Orthop Sci 16 : 424-432, 2011
PubMed
5) Fujii T, et al : Prevalence of low back pain and factors associated with chronic disabling back pain in Japan. Eur Spine J 22 : 432-438, 2013
PubMed
6) Patrick SW, et al : Neonatal abstinence syndrome and associated health care expenditures. United States, 2000-2009. JAMA 307 : 1934-1940, 2012
PubMed
7) Dworkin RH, et al : Pharmacologic management of neuropathic pain : evidence-based recommendations. Pain 132 : 237-251, 2007
PubMed
8) Attal N, et al ; EFNS Task Force : EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13 : 1153-1169, 2006
PubMed
9) Moulin DE, et al ; Canadian Pain Society : Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 12 : 13-21, 2007
PubMed

解説

P.17 掲載の参考文献
1) Dubin AE, et al : Nociceptors : the sensors of the pain pathway. J Clin Invest 120 : 3760-3772, 2010
PubMed
2) Meyer RA, et al : Peripheral mechanisms of cutaneous nociception. Wall and Melzack's Textbook of Pain, 5th ed, McMahon SB, et al eds, Elsevier Churchill Livingstone, 3-34, 2005
 
3) Hudspith MJ, et al : Chapter 23-Physiology of pain. Foundations of Anesthesia, Basic Sciences for Clinical Practice, 2nd ed, Hemmings HC Jr, et al eds, MBBS MD FRCA, Mosby, 267-285, 2006
 
4) Ling LJ, et al : The central projection of unmyelinated (C) primary afferent fibers from gastrocnemius muscle in the guinea pig. J Comp Neurol 461 : 140-150, 2003
PubMed
5) 厚生労働省研究班 : 痛みの教育コンテンツ
 
6) Kim SE, et al : The role of drosophilia Piezo in mechanical nociception. Nature 483 : 209-212, 2012
 
7) Woolf CJ, et al : Plasticity and Pain : role of the dorsal horn. Wall and Melzack's Textbook of Pain, McMahon SB, et al eds, 5th ed, Elsevier Churchill Livingstone, Edinburgh, 91-106, 2005
 
8) Almeida TF, et al : Afferent pain pathways : a neuroanatomical review. Brain Res 1000 : 40-56, 2004
PubMed
9) Basbaum AI, et al : The perception of pain. Principles of Neural Science, 4th ed, McGraw-Hill, 472-491, 2000
 
10) Willis WD Jr, et al : The role of the dorsal column pathway in visceral nociception. Curr Pain Headache Rep 5 : 20-26, 2001
PubMed
11) Craig AD : Pain mechanisms : labeled lines versus convergence in central processing. Ann Rev Neurosci 26 : 1-30, 2003
PubMed
12) Bushnell MC, et al : Representation of pain in the brain. Wall and Melzack's Textbook of Pain, McMahon SB, et al eds, 5th ed, Elsevier Churchill Livingstone, Edinburgh, 104-124, 2005
 
13) Fields HL, et al : Central nervous system mechanisms of pain modulation. Wall and Melzack's Textbook of Pain, McMahon SB, et al eds, 5th ed, Elsevier Churchill Livingstone Edinburgh, 125-142, 2005
 
P.20 掲載の参考文献
1) Montell VK : TRP channels. Annu Rev Biochem 76 : 387-417, 2007
 
2) Nilius B, et al : Transient receptor potential cation channels in disease. Physiol Rev 87 : 165-217, 2007
PubMed
3) Caterina MJ, et al : The capsaicin receptor : a heat-activated ion channel in the pain pathway. Nature 389 : 816-824, 1997
PubMed
4) Tominaga M, et al : Thermosensation and pain. J Neurobiol 61 : 3-12, 2004
 
5) Caterina MJ, et al : Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288 : 306-313, 2000
PubMed
6) Caterina MJ, et al : A capsaicin-receptor homologue with a high threshold for noxious heat. Nature 398 : 436-441, 1999
PubMed
7) Park U, et al : TRP vanilloid 2 knock-out mice are susceptible to perinatal lethality but display normal thermal and mechanical nociception. J Neurosci 31 : 11425-11436, 2011
PubMed
8) Mandadi S, et al : TRPV3 in keratinocytes transmits temperature information to sensory neurons via ATP. Pflugers Arch 458 : 1093-1102, 2009
PubMed
9) Vriens J, TRPM3 is a nociceptor channel involved in the detection of noxious heat. Neuron 70 : 482-494, 2011
PubMed
10) Cho H, et al : The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons. Nat Neurosci 15 : 1015-1021, 2012
PubMed
P.25 掲載の参考文献
1) Julius D, et al : Molecular mechanisms of nociception. Nature 413 : 203-210, 2001
PubMed
2) Meyer RA, et al : Peripheral mechanisms of cutaneous nociception. Textbook of Pain, chapt 1. McMahon SB, et al eds, Elsevier Churchill Livingstone, Philadelphia, 3-34, 2005
 
3) Julius D, et al : Cellular and molecular properties of primary afferent neurons. Textbook of Pain, chapt 2, McMahon SB, et al eds, Elsevier Churchill Livingstone, Philadelphia, 35-48, 2005
 
4) McMahon SB, et al : Inflammatory mediators and modulators of pain. Textbook of Pain, chapt 3. McMahon SB, et al eds, Elsevier Churchill Livingstone, Philadelphia, 49-72, 2005
 
5) Kidd BL, et al : Mechanisms of inflammatory pain. Br J Anaesth 87 : 3-11, 2001
PubMed
6) Nilius B, et al : Transient receptor potential cation channels in disease. Physiol Rev 87 : 165-217, 2007
PubMed
7) Lingueglia E : Acid-sensing ion channels in sensory perception. J Biol Chem 282 : 17324-17329, 2007
 
8) Richardson JD, et al : Cellular mechanisms of neurogenic inflammation. J Pharmacol 302 : 839-845, 2002
 
9) Indo Y : Nerve growth factor and the physiology of pain : lessons from congenital insensitivity to pain with anhidrosis. Clin Genet 82 : 341-350, 2012
PubMed
10) Carlton SM : Peripheral excitatory amino acids. Curr Opin Pharmacol 1 : 52-56, 2001
PubMed
11) Carlton SM, et al : Peripheral GABAA receptors : evidence for peripheral primary afferent depolarization. Neurosci 93 : 713-722, 1999
 
12) Ossovskaya VS, et al : Protease-activated receptors : Contribution to physiology and disease. Physiol Rev 84 : 579-621, 2004
PubMed
13) Ji RR, et al : p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 26 : 57-68, 2002
 
14) Numazaki M, et al : Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues. J Biol Chem 277 : 13375-13378, 2002
PubMed
P.33 掲載の参考文献
1) Dib-Hajj SD, et al : Sodium channels in normal and pathological pain. Annu Rev Neurosci 33 : 325-347, 2010
PubMed
2) Ito A, et al : Anti-hyperalgesic effects of calcitonin on neuropathic pain interacting with its peripheral receptors. Molecular Pain 8 : 42, 2012
PubMed
3) Inoue M, et al : Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 10 : 712-718, 2004
PubMed
4) Woolf CJ, et al : Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 355 : 75-78, 1992
PubMed
5) Okamoto M, et al : Functional reorganization of sensory pathways in the rat spinal dorsal horn following peripheral nerve injury. J Physiol 532 : 241-250, 2001
PubMed
6) Ruscheweyh R, et al : Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy. Mol Pain 7 : 20, 2011
PubMed
7) Zeilhofer HU, et al : Chronic pain states : pharmacological strategies to restore diminished inhibitory spinal pain control. Annu Rev Pharmacol Toxicol 52 : 111-133, 2012
PubMed
8) Ito A, et al : Mechanisms for ovariectomy-induced hyperalgesia and its relief by calcitonin : par ticipation of 5-HT1A-like receptor on C-afferent terminals in substantia gelatinosa of the rat spinal cord. J Neurosci 20 : 6302-6308, 2000
 
9) Tsuda M, et al : Purinergic system, microglia and neuropathic pain. Curr Opin Pharmacol 12 : 74-79, 2012
PubMed
10) Prescott SA, et al : Reduction of anion reversal potential subver ts the inhibitory control of firing rate in spinal lamina I neurons : towards a biophysical basis for neuropathic pain. Mol Pain 2 : 32, 2006
 
11) Coull JA, et al : BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438 : 1017-1021, 2005
PubMed
12) V. S. ラマチャンドラン : 脳のなかの幽霊, ふたたび, 山下篤子訳, 角川書店, 東京, 2009
 
13) 丸太俊彦 : 痛みの心理学, 中央公論社, 東京, 1989
 
14) Zhao MG, et al : Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. Neuron 47 : 859-872, 2005
PubMed
P.37 掲載の参考文献
1) Hayashida K, et al : Brain derived nerve growth factor induces spinal noradrenergic fiber sprouting and enhances clonidine analgesia following nerve injury in rats. Pain 136 : 348-355, 2008
PubMed
2) Hayashida K, et al : Spinal alpha 2-adrenoceptor-mediated analgesia in neuropathic pain reflects brain-derived nerve growth factor and changes in spinal cholinergic neuronal function. Anesthesiology 113 : 406-412, 2010
PubMed
3) Kishore-Kumar R, et al : Single doses of the serotonin agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain. Pain 37 : 223-227, 1989
 
4) Nakajima K, et al : The nociceptive mechanism of 5-hydroxytryptamine released into the peripheral tissue in acute inflammatory pain in rats. Eur J Pain 13 : 441-447, 2009
PubMed
5) Obata H, et al : Interactions of 5-HT2 receptor agonists with acetylcholine in spinal analgesic mechanisms in rats with neuropathic pain. Brain Res 965 : 114-120, 2003
PubMed
6) Suzuki R, et al : Bad news from the brain : descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 25 : 613-617, 2004
PubMed
7) Peters CM, et al : Lack of analgesic ef ficacy of spinal ondansetron on thermal and mechanical hypersensitivity following spinal nerve ligation in the rat. Brain Res 1352 : 83-93, 2010
 
8) Tuveson B, et al : Ondansetron, a 5HT3-antagonist, does not alter dynamic mechanical allodynia or spontaneous ongoing pain in peripheral neuropathy. Clin J Pain 27 : 323-329, 2011
PubMed
9) Hayashida K, et al : Ondansetron reverses antihypersensitivity from clonidine in rats after peripheral nerve injury : role of gamma-aminobutyric acid in alpha 2-adrenoceptor and 5-HT3 serotonin receptor analgesia. Anesthesiology 117 : 389-398, 2012
PubMed
10) Finnerup NB, et al : The evidence for pharmacological treatment of neuropathic pain. Pain 150 : 573-581, 2010
PubMed
11) Hayashida K, et al : Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery. Anesthesiology 106 : 557-562, 2007
PubMed
12) Hayashida K, et al : Gabapentin acts within the locus coeruleus to alleviate neuropathic pain. Anesthesiology 109 : 1077-1084, 2008
PubMed
13) Yoshizumi M, et al : Gabapentin inhibits gamma-amino butyric acid release in the locus coeruleus but not in the spinal dorsal horn after peripheral nerve injury in rats. Anesthesiology 116 : 1347-1353, 2012
PubMed
14) Clayton BA, et al : Oral donepezil reduces hypersensitivity after nerve injury by a spinal muscarinic receptor mechanism. Anesthesiology 106 : 1019-1025, 2007
PubMed
15) Hayashida K, et al : Multiplicative interactions to enhance gabapentin to treat neuropathic pain. Eur J Pharmacol 598 : 21-26, 2008
PubMed
P.49 掲載の参考文献
1) Chizh BA, et al : Novel approaches to targeting glutamate receptors for the treatment of chronic pain. Amino Acids 23 : 169-176, 2002
PubMed
2) Herrero JF, et al : Wind-up of spinal cord neurones and pain sensation : much ado about something? Prog Neurobiol 61 : 169-203, 2000
PubMed
3) Ji RR, et al : Central sensitization and LTP : do pain and memory share similar mechanisms? Trends Neurosci 26 : 696-705, 2003
PubMed
4) Kuzumaki N, et al : Chronic pain-induced astrocyte activation in the cingulate cortex with no change in neural or glial dif ferentiation from neural stem cells in mice. Neurosci Lett 415 : 22-27, 2007
 
5) Narita M, et al : Sleep disturbances in a neuropathic painlike condition in the mouse are associated with altered GABAergic transmission in the cingulate cor tex. Pain 152 : 1358-1372, 2011
 
6) Hoyer D, et al : International Union of Pharmacology classification of receptors for 5-hydroxytryptamine. Pharmacol Rev 46 : 149-163, 1994
 
7) Imbe H, et al : The role of descending serotonergic neurons in the RVM in chronic pain state. Bone Joint Nerve 2 : 223-229, 2012
 
8) James R, et al : Subtypes of functional α1 -and α2 adrenoceptors. Eur J Pharmacol 13 : 1-15, 1998
 
9) Abood ME, et al : Neurobiology of marijuana abuse. Trends Pharmacol Sci 13 : 201-206, 1992
PubMed
10) De Pretrocellis L, et al : The endocannabinoid system : a general view and latest additions. Br J Pharmacol 141 : 765-774, 2004
 
11) Kavoussi R : Pregabalin : From molecule to medicine. Eur Neuropsychopharmacol 16 (suppl 2) : S128-133, 2006
 
12) Granier S, et al : A new era of GPCR structural and chemical biology. Nat Chem Biol 18 : 670-673, 2012
 
P.57 掲載の参考文献
1) Cervero F, et al : Visceral pain. Lancet 353 : 2145-2148, 1999
PubMed
2) Burnstock G : Targeting the visceral purinergic system for pain control. Curr Opin Pharmacol 12 : 80-86, 2012
PubMed
3) Camilleri M : Serotonergic modulation of visceral sensation : lower gut. Gut 51 (suppl 1) : i81-86, 2002
 
4) Matsumoto-Miyai K, et al : The regulatory mechanism underlying ATP release from urothelium. Advances in Medicine and Biology, Berhardt LV ed, Nova Science Publishers, Hauppauge, 203-215, 2011
 
5) Pedersen KV, et al : Visceral pain originating from the upper urinary tract. Urol Res 38 : 345-355, 2010
PubMed
6) Sengupta JN : Visceral pain : the neurophysiological mechanism. Handb Exp Pharmacol 194 : 31-74, 2009
PubMed
7) 尾崎紀之ほか : 消化管の痛み. 痛み研究のアプローチ, 河谷正仁編, 真興交易医書出版部, 東京, 194-199, 2006
 
8) Bielefeldt K, et al : Visceral pain : basic mechanisms. Wall and Melzack's Textbook of Pain, McMahon SB, et al eds, 5th ed, Elsevier, Churchill Livingstone, Philadelphia, 721-736, 2006
 
9) 河谷正仁ほか : 膀胱痛. 痛み研究のアプローチ, 河谷正仁編, 真興交易医書出版部, 東京, 200-206, 2006
 
10) Blackshaw LA, et al : TRP channels : new targets for visceral pain. Gut 59 : 126-135, 2010
PubMed
P.66 掲載の参考文献
1) 小山なつ : 痛みと鎮痛の基礎知識 [上] 基礎編. 技術評論社, 東京, 131-138, 2010
 
2) McMahon SB, et al : Chapter 3. Inflammatory mediators and modulators of pain. Wall and Melzack's Textbook of Pain, 5th ed, McMahon SB, et al eds, Elsevier Churchill Livingstone, London, 49-72, 2005
 
3) Meyer RA, et al : Chapter 1 Peripheral mechanisms of cutaneous nociception. Wall and Melzack's Textbook of Pain, 5th ed, McMahon SB, et al eds, Elsevier, Churchill Livingstone, London, 3-34, 2005
 
4) Dray A : Inflammatory mediators of pain. Br Anaesth 75 : 125-131, 1995
PubMed
5) Kidd BL, et al : Mechanisms of inflammatory pain. Br Anaesth 87 : 3-11, 2001
PubMed
6) Tominaga M : Nociception and TRP channels. Handb Exp Pharmacol 179 : 489-505, 2007
PubMed
7) Patapoutian A, et al : Transient receptor potential channels : targeting pain at the source. Nat Rev Drug Discov 8 : 55-68, 2009
PubMed
8) Sugiura T, et al : Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1. J Neurophysiol 88 : 544-548, 2002
PubMed
9) Tominaga M, et al : Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA 98 : 6951-6956, 2001
PubMed
10) Coste B, et al : Piezo 1 and Piezo 2 are essential components of distinct mechanically activated cation channels. Science 330 : 55-60, 201
 
P.74 掲載の参考文献
1) Sandkuhler J : Models and mechanisms of hyperalgesia and allodynia. Physiol Rev 89 : 707-758, 2009
PubMed
2) Devor M : Ectopic discharge in Abeta afferents as a source of neuropathic pain. Exp Brain Res 196 : 115-128, 2009
PubMed
3) Wang W, et al : Are voltage-gated sodium channels on the dorsal root ganglion involved in the development of neuropathic pain? Mol Pain 7 : 16, 2011
PubMed
4) Chung JM et al : Sodium channels and neuropathic pain. Novar tis Found Symp 261 : 19-27, discussion 27-31, 47-54, 2004
 
5) Waxman SG, et al : Sodium channels and pain. Proc Natl Acad Sci USA 96 : 7635-7639, 1999
PubMed
6) Nassar MA, et al : Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice. Mol Pain 2 : 33, 2006
PubMed
7) Abe T, et al : Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain. Eur J Neurosci 22 : 1445-1454, 2005
PubMed
8) Liu XJ, et al : Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex. Nat Med 14 : 1325-1332, 2008
PubMed
9) Kawasaki Y, et al : Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. J Neurosci 24 : 8310-8321, 2004
 
10) Gao X, et al : Enhancement of NMDA receptor phosphorylation of the spinal dorsal horn and nucleus gracilis neurons in neuropathic rats. Pain 116 : 62-72, 2005
PubMed
11) Basbaum AI, et al : Endogenous pain control mechanisms : review and hypothesis. Ann Neurol 4 : 451-462, 1978
PubMed
12) Sandkuhler J : The organization and function of endogenous antinociceptive systems. Prog Neurobiol 50 : 49-81, 1996
PubMed
13) Baba H, et al : Removal of GABAergic inhibition facilitates polysynaptic A fiber-mediated excitatory transmission to the superficial spinal dorsal horn. Mol Cell Neurosci 24 : 818-830, 2003
 
14) Moore KA, et al : Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 22 : 6724-6731, 2002
PubMed
15) Prescott SA, et al : Reduction of anion reversal potential subver ts the inhibitory control of firing rate in spinal lamina I neurons : towards a biophysical basis for neuropathic pain. Mol Pain 2 : 32, 2006
 
16) Coull JA, et al : Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 424 : 938-942, 2003
PubMed
17) Coull JA, et al : BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438 : 1017-1021, 2005
PubMed
18) Michael GJ, et al : Axotomy results in major changes in BDNF expression by dorsal root ganglion cells : BDNF expression in large trkB and trkC cells, in pericellular baskets, and in projections to deep dorsal horn and dorsal column nuclei. Eur J Neurosci 11 : 3539-3551, 1999
PubMed
19) 小幡英章 : 下行性抑制系と慢性疼痛. 麻酔 54 : S173-S182, 2005
 
20) Tsuda M, et al : P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 : 778-783, 2003
PubMed
21) Kobayashi K, et al : Induction of the P2X7 receptor in spinal microglia in a neuropathic pain model. Neurosci Lett 504 : 57-61, 2011
 
22) Kobayashi K, et al : P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J Neurosci 28 : 2892-2902, 2008
PubMed
P.81 掲載の参考文献
1) 林田眞和ほか : 術後痛-術後痛の強さとオピオイド必要量の多様性をいかに克服するか-. 麻酔 58 : 1086-1092,2009
Medical*Online
2) フェントス(R) テープ (薬剤添付文書). 久光製薬株式会社, 協和発酵キリン株式会社, 2011
 
3) Maitre PO, et al : Population pharmacokinetics of alfentanil : the average dose-plasma concentration relationship and interindividual variability in patients. Anesthesiology 66 : 3-12, 1987
PubMed
4) Ausems ME, et al : Plasma concentration of alfentanil required to supplement nitrous oxide anesthesia for general surgery. Anesthesiology 65 : 362-373, 1986
PubMed
5) Gourlay GK, et al : Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain. Anesth Analg 67 : 329-337, 1988
PubMed
6) Fukuda K : Opioids. Miller's Anesthesia, Miller RD ed, 7th ed, Churchill-Livingstone, Philladelphia, 769-824, 2010
 
7) Martin C, et al : Pharmacokinetic-pharmacodynamic modeling in acute and chronic pain : an overview of the recent literature. Expert Rev Clin Pharmacol 4 : 719-728, 2011
 
8) Macintyre PE : Safety and efficacy of patient-controlled analgesia. Brit J Anaesth 87 : 36-46, 2001
PubMed
9) 林田眞和ほか : 遺伝子多型とオピオイド感受性-μ-オピオイド受容体遺伝子A118G多型を中心に-. 臨麻 36 : 1591-1598, 2012
Medical*Online
10) Gregori SD, et al : Morphine metabolism, transport and brain disposition. Metab Brain Dis 27 : 1-5, 2012
 
11) Trescot AM, et al : Opioid pharmacology. Pain Physician 11 : S133-153, 2008
PubMed
12) Zhang W, et al : CYP3A4*1G genetic polymorphism influence CYP3A activity and response to fentanyl in Chinese gynecologic patients. Eur J Pharmacol 66 : 61-66, 2010
 
13) Samer CF, et al : The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone. Brit J Pharmacol 160 : 907-918, 2010
 
14) Johansson I, et al : Genetic polymorphism and toxicology-with emphasis on cytochrome p450. Toxicol Sci 120 : 1-13, 2011
PubMed
15) 林田眞和 : 帯状疱疹後神経痛の治療-薬物療法. 帯状疱疹Up-to-date, 稲田英一編, 診断と治療社, 東京, 108-113, 2012
 
P.83 掲載の参考文献
1) Moran MM, et al : Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov 10 : 601-620, 2011
PubMed
2) Andersson DA, et al : TRPA1 mediates : spinal antinociception induced by acetaminophen and the cannabinoid Delta (9) -tetrahydrocannabiorcol. Nat Commun 2 : 551, 2011
PubMed
3) Kim YH, et al : TRPV1 in GABAergic interneurons mediates neuropathic mechanical allodynia and disinhibition of the nociceptive circuitry in the spinal cord. Neuron 74 : 640-647, 2012
PubMed
4) Binshtok AM, et al : Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers. Nature 449 : 607-610, 2007
PubMed
P.91 掲載の参考文献
1) American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 57 : 1331-1346, 2009
 
2) http://www.mhlw.go.jp/toukei/saikin/hw/kanja/08/index.html.
 
3) Johnson RW, et al : Herpes zoster and postherpetic neuralgia : optimizing management in the elderly patient. Drugs Aging 25 : 991-1006, 2008
PubMed
4) Wegman A, et al : Nonsteroidal antiinflammatory drugs or acetaminophen for osteoarthritis of the hip or knee? A systematic review of evidence and guidelines. J Rheumatol 31 : 344-354, 2004
 
P.96 掲載の参考文献
1) Morton NS : The pain-free ward : myth or reality. Pediatric Anesthesia 22 : 527-529, 2012
PubMed
2) Good Practice in Postoperative and Procedural Pain Management, 2nd ed. 2012. Pediatric Anesthesia 22 (suppl 1) : 1-79, 2012
 
3) Davis PJ, et al : Smith's Anesthesia for Infants and Children, 8th ed, Elsevier Health Sciences, Philadelphia, 418-451, 2011
 
4) 照井克生 : 帝王切開・無痛分娩におけるロピバカインの臨床使用の実際. 日臨麻会誌 29 : 708-717, 2009
Medical*Online
5) 香川哲郎ほか : 小児の周術期疼痛管理. ペインクリニック 33 : 7-14, 2012
Medical*Online
P.101 掲載の参考文献
1) 武井研二ほか : アセトアミノフェン坐剤の併用がジアゼパム坐剤の直腸からの吸収に及ぼす影響. 日小児会誌 100 : 1347-1355, 1996
 
2) Nelson L, et al : Transdermal fentanyl : pharmacology and toxicology. J Med Toxicol 5 : 230-241, 2009
PubMed
3) Flores MP, et al : Topical analgesics. Rev Bra Anestesiol 62 : 244-252, 2012
 
4) Mercadante S : Problems of long-term spinal opioid treatment in advanced cancer patients. Pain 79 : 1-13, 1999
PubMed
P.106 掲載の参考文献
1) Mackay S, et al : Biliary pain. Aust Fam Physicia 33 : 977-981, 2004
 
2) Colli A, et al : Meta-analysis : nonsteroidal anti-inflammatory drugs in biliary colic. Aliment Pharmacol Ther 35 : 1370-1378, 2012
PubMed
3) Kumar A, et al : Comparison of the effect of diclofenac with hyoscine-N-butylbromide in the symptomatic treatment of acute biliary colic. ANZ J Surg 74 : 573-576, 2004
PubMed
4) Teichman JMH : Acute renal colic from ureteral calculus. N Engl J Med 350 : 684-693, 2004
PubMed
5) Cordell WH, et al : Indomethacin suppositories versus intravenously titrated morphine for the treatment of ureteral colic. Ann Emerg Med 23 : 262-269, 1994
PubMed
6) Larkin GL, et al : Ef ficacy of ketorolac tromethamine versus meperidine in the ED treatment of acute renal colic. Am J Emerg Med 17 : 6-10, 1999
 
7) Lopes T, et al : An assessment of the clinical efficacy of intranasal desmopressin spray in the treatment of renal colic. BJU Int 87 : 322-325, 2001
PubMed
8) Phillips E, et al : Celecoxib in the management of acute renal colic : a randomized controlled clinical trial. Urology 74 : 994-999, 2009
PubMed
9) Kober A, et al : Local active warming : an effective treatment for pain, anxiety and nausea caused by renal colic. J Urol 170 : 741-744, 2003
 
10) Holdgate A, et al : Systemactic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic. BMJ 329 : 1019, 2004
 
11) Carley SD : Towards evidence based emergency medicine : best BETs from the Manchester Royal Infirmary. Emerg Med J 22 : 652-655, 2005
 
12) Song SW, et al : Butylscopolammonium bromide does not provide additional analgesia when combined with morphine and ketorolac for acute renal colic. Emerg Med Australas 24 : 144-150, 2012
 
13) Cervero F : Mechanisms of acute visceral pain. Br Med Bull 47 : 549-560, 1991
PubMed
14) Mercadante S, et al : Analgesic effects of nonsteroidal anti-inflammatory drugs in cancer pain due to somatic or visceral mechanisms. J Pain Symptom Manage 17 : 351-356, 1999
 
P.110 掲載の参考文献
1) Meyer RA, et al : Peripheral mechansms of cutaneous nociception. Wall and Melzack's Textbook of Pain, McMahon SB, et al eds, 5th ed, Elsevier, Churchill Livingstone, London, 3-34, 2005
 
2) Devor M : Neuropathic pain and injured nerve : peripheral mechanisms. Br Med Bull 47 : 619-630, 1991
PubMed
3) Inoue M, et al : Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 10 : 712-718, 2004
PubMed
4) Fukuoka T, et al : Change in mRNAs for neuropeptides and the GABA (A) receptor in dorsal root ganglion neurons in a rat experimental neuropathic pain model. Pain 78 : 13-26, 1998
 
5) Fukuoka T, et al : Brain-derived neurotrophic factor increases in the uninjured dorsal root ganglion neurons in selective spinal nerve ligation model. J Neurosci 21 : 4891-4900, 2001
 
6) Ji RR, et al : Central sensitization and LTP : do pain and memory share similar mechanisms? Trends Neurosci 26 : 696-705, 2003
PubMed
7) Woolf CJ, et al : Relative effectiveness of C primary afferent fibers of different origins in evoking a prolonged facilitation of the flexor reflex in the rat. J Neurosci 6 : 1433-1442, 1986
 
8) Milligan ED, et al : Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10 : 23-36, 2009
PubMed
9) Coull JA, et al : BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438 : 1017-1021, 2005
PubMed
10) Suzuki R, et al : Bad news from the brain : descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 25 : 613-617, 2004
PubMed
11) Dworkin RH, et al : Pharmacologic management of neuropathic pain : evidence-based recommendations. Pain 132 : 237-251, 2007
PubMed
12) 日本ペインクリニック学会神経障害性疼痛薬物療法ガイドライン作成ワーキンググループ編 : 神経障害性疼痛薬物療法ガイドライン, 真興交易医書出版部, 東京, 2011
 
P.113 掲載の参考文献
1) Devor M : Response of nerves to injury in relation to neuropathic pain. Wall and Melzack's Textbook of Pain, McMahon SB, et al eds, 5th ed, Elsevier Churchill Livingstone, London, 905-927, 2005
 
2) Mao J, et al : Systemic lidocaine for neuropathic pain relief. Pain 87 : 7-17, 2000
PubMed
3) Wang W, et al : Are voltage-gated sodium channels on the dorsal root ganglion involved in the development of neuropathic pain? Mol Pain 7 : 16, 2011
PubMed
4) Nystrom B, et al : Microelectrode recordings from transected ner ves in amputees with phantom limb pain. Neurosci Lett 27 : 211-216, 1981
 
5) Seltzer Z, et al : Ephaptic transmission in chronically damaged peripheral nerves. Neurology 7 : 1061-1064, 1979
PubMed
6) Lisney SJ, et al : Afterdischarge and interactions among fibers in damaged peripheral nerve in the rat. Brain Res 415 : 122-136, 1987
PubMed
7) Rappaport ZH, et al : Trigeminal neuralgia : the role of self-sustaining discharge in the trigeminal ganglion. Pain 56 : 127-138, 1994
 
8) Attal N, et al : Translating basic research on sodium channels in human neuropathic pain. J Pain 7 (1 suppl 1) : S31-37, 2006
 
9) Dick IE, et al : Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. J Pain 8 : 315-324, 2007
 
P.118 掲載の参考文献
1) 伊藤正男ほか編 : 医学書院医学大辞典, 医学書院, 東京, 1078, 2003
 
2) Magerl W, et al : Secondary tactile hypoesthesia : a novel type of pain-induced somatosensory plasticity in human subjects. Neurosci Lett 361 : 136-139, 2004
PubMed
3) Geber C, et al : Numbness in clinical and experimental pain : a cross-sectional study exploring the mechanisms of reduced tactile function. Pain 139 : 73-81, 2008
 
4) Moriwaki K, et al : Topographical features of cutaneous tactile hypoesthetic and hyperesthetic abnormalities in chronic pain. Pain 81 : 1-6, 1999
PubMed
5) Hofbauer RK, et al : Thermal and tactile sensory deficits and allodynia in a nerve-injured patient : a multimodal psychophysical and functional magnetic resonance imaging study. Clin J Pain 22 : 104-108, 2006
 
6) Westermann A, et al : Pain-associated mild sensory deficits without hyperalgesia in chronic non-neuropathic pain. Clin J Pain 27 : 782-789, 2011
PubMed
7) Foulkes T, et al : Mechanisms of cold pain. Channels 1 : 154-160, 2007
PubMed
8) Walk D, et al : Quontitative sensory testing and mapping : a review of nonautomated quantitative methods for examination of the patient with neuropathic pain. Clin J Pain 25 : 632-640, 2009
PubMed
9) Yamashita T, et al : A quantitative analysis of sensory function in lumbar radiculopathy using current perception threshold testing. Spine 27 : 1567-1570, 2002
PubMed
10) Krumova EK, et al : Neuropathic pain : is quantitative sensory testing helpful? Curr Diab Rep 12 : 393-402, 2012
PubMed
11) Walk D, et al : Symptom duration and clinical features in painful sensory neuropathy with and without nerve conduction abnormalities. J Neurol Sci 214 : 3-6, 2003
PubMed
12) Hoitsma E, et al : Small fiber neuropathy : a common and important clinical disorder. J Neurol Sci 227 : 119-130, 2004
PubMed
13) Marchettini P, et al : Painful peripheral neuropathies. Curr Neuropharmacol 4 : 175-181, 2006
PubMed
14) Singer MA, et al : Idiopathic neuropathy : new paradigms, new promise. J Peripher Nerv Syst Suppl 2 : 43-49, 2012
 
15) Mold JW, et al : The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract 17 : 309-318, 2004
PubMed
16) Vrancken AF, et al : Drug therapy for chronic idiopathic axonal polyneuropathy. Cochrane Database Syst Rev 2 : CD003456, 2004
PubMed
17) Richardson JK, et al : Peripheral neuropathy : an oftenoverlooked cause of falls in the elderly. Postgrad Med 99 : 161-172, 1996
PubMed
18) Jensen PG, et al : Management of painful diabetic neuropathy. Drugs Aging 18 : 737-749, 2001
PubMed
19) Kastenbauer T, et al : The prevalence of symptoms of sensorimotor and automatic neuropathy in type 1 and type 2 diabetic subjects. J Diabetes Complications 18 : 27-31, 2004
 
20) Siemionow M, et al : Diabetic neuropathy : pathogenesis and treatment. J Reconstr Microsurg 20 : 241-252, 2004
PubMed
21) Vincent AM, et al : Diabetic neuropathy : cellular mechanisms as therapeutic targets. Nat Rev Neurol 7 : 573-583, 2011
PubMed
22) Habib AA, et al : Therapeutic strategies for diabetic neuropathy. Curr Neurol Neurosci Rep 10 : 92-100, 2010
PubMed
23) Quasthoff S : The role of axonal ion conductances in diabetic neuropathy : a review. Muscle Nerve 21 : 1246-1255, 1998
PubMed
24) Wolf S, et al : Chemotherapy-induced peripheral neuropathy : prevention and treatment strategies. Eur J Cancer 44 : 1507-1515, 2008
PubMed
25) Argyriou AA, et al : Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents. J BUON 15 : 435-446, 2010
PubMed
26) Gonzalez-Duarte A, et al : Managing HIV peripheral neuropathy. Curr HIV/AIDS Rep 4 : 114-118, 2007
PubMed
27) Wulff EA, et al : HIV-associated peripheral neuropathy : epidemiology, pathophysiology and treatment. Drugs 59 : 1251-1260, 2000
PubMed
28) Karroum EG, et al : Sensations in restless legs syndrome. Sleep Med 13 : 402-408, 2012
PubMed
29) Bracker MD, et al : The numb and hand. Am Farm Physician 51 : 103-116, 1995
 
30) Zanette G, et al : Extra-median spread of sensory symptoms in carpal tunnel syndrome suggests the presence of pain-related mechanisms. Pain 122 : 264-270, 2006
PubMed
P.120 掲載の参考文献
1) Ikoma A, et al : The neurobiology of itch. Nat Rev Neurosci 7 : 535-547, 2006
PubMed
2) van Laarhoven AI, et al : Heterotopic pruritic conditioning and itch-analogous to DNIC in pain? Pain 149 : 332-337, 2010
PubMed
3) Xiao B, et al : Scratching the surface : a role of pain-sensing TRPA1 in itch. Nat Neurosci 14 : 540-542, 2011
PubMed
4) Sun YG, et al : Cellular basis of itch sensation. Science 18 : 1531-1534, 2009
 
5) Yosipovitch G, et al : The brain processing of scratching. J Invest Dermatol 128 : 1806-1811, 2008
PubMed
6) Liu XY, et al : Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell 147 : 447-458, 2011
PubMed
P.126 掲載の参考文献
1) Fukuda K : Opioids. Miller's Anesthesia, Miller RD, ed, 7th ed, Churchill Livingstone, New York, 769-824, 2009
 
2) Manglik A, et al : Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature 485 : 321-326, 2012
 
3) Waldhoer M, et al : Opioid receptors. Annu Rev Biochem 73 : 953-990, 2004
PubMed
4) Pasternak GW : Molecular insights into mu opioid pharmacology : From the clinic to the bench. Clin J Pain 26 (suppl 10) : S3-9, 2010
 
5) Liu XY, et al : Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell 147 : 447-458, 2011
PubMed
6) Fields HL, et al : Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 14 : 219-245, 1991
PubMed
7) Stein C : The control of pain in peripheral tissue by opioids. N Engl J Med 332 : 1685-1690, 1995
PubMed
P.131 掲載の参考文献
1) 世界保健機関編, 武田文和訳 : がんの痛みからの解放-WHO方式がん疼痛治療法-, 金原出版, 東京, 45, 1987
 
2) 小野秀樹 : 1. モルヒネ (塩酸モルヒネ, 硫酸モルヒネ), 臨床緩和医療薬学, 日本緩和医療薬学会編, 真興交易医書出版部, 東京, 112-116, 2008
 
3) 有田英子 : 4. 強オピオイド (i. モルヒネ製剤). 癌性疼痛, 花岡一雄編, 克誠堂出版, 東京, 60-68, 2010
 
4) Glare P : Morphine. Opioids in Cancer Pain, Davis M ed, 2nd ed, Oxford University Press, New York, 91-120, 2009
 
5) Narabayashi M, et al : Opioid rotation from oral morphine to oxycodone in cancer patients with intolerable adverse effects : an open-label trial. Jpn J Clin Oncol 38 : 296-304, 2008
PubMed
6) Twycross R, et al : Swi tching opioids. Symptom Management in Advanced Cancer, 3rd ed, Radcliffe Medical Press, Oxon, 378-379, 2002
 
7) 下山直人ほか : がん性疼痛の治療. 臨床麻酔学全書, 花岡一雄編著, 真興交易医書出版, 東京, 652-663, 2002
 
8) 鈴木 勉ほか : モルヒネの低用量では, なぜ副作用しかでないのか? オピオイド治療 課題と新潮流, 鎮痛薬・オピオイドペプチド研究会編, ミクス, 東京, 25-34, 2001
 
9) Thomas J, et al : Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 358 : 2232-2343, 2008
 
10) 厚生労働省・日本医師会監修 : 第4章 痛みのマネジメント. がん緩和ケアに関するマニュアル, 日本ホスピス・緩和ケア振興財団, 大阪, 21, 2010
 
P.135 掲載の参考文献
1) Biancofiore G : Oxycodone controlled release in cancer pain management, The Clin Risk Manag 2 : 229-234, 2006
PubMed
2) Lalovic B, et al : Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects : Role of circulating active metabolites, Clin Pharmacol Ther 79 : 461-479, 2006
PubMed
3) がん疼痛の治療 : がん情報サービス, http://ganjoho.jp/professional/med_info/care.html#16
 
4) Mucci-LoRusso P, et al : Controlled release oxycodone compared with controlled-release morphine in the treatment of cancer pain : a randomized, double-blind, parallelgroup study. Eur J Pain 2 : 239-249, 1998
PubMed
5) Narabayashi M, et al : Opioid rotation from oral morphine to oxycodone in cancer patients with intolerable adverse effects : An open-label trial. Jap J Clin Oncol 38 : 296-304, 2008
 
6) Anderson DT, et al : Oxycontin : the concept of a "ghost pill" and the postmortem tissue distribution of oxycodone in 36 cases. J Anal Toxicol 26 : 448-459, 2002
 
7) Watson CP, et al : Efficacy of oxycodone in neuropathic pain : a randomized trial in postherpetic neuralgia, Neurology 50 : 1837-1841, 1998
PubMed
8) Watson CPN, et al : Controlled-release oxycodone relieves neuropathic pain : a randomized controlled trial in painful diabetic neuropathy. Pain 105 : 71-78, 2003
PubMed
9) Gimble JS, et al : Controlled-release oxycodone for pain in diabetic neuropathy : a randomized controlled trial. Neurology 60 : 927-934, 2003
 
P.140 掲載の参考文献
1) 葛巻直子ほか : オピオイドの作用機序. Modern Physician 32 : 10-15, 2012
 
2) Gustein HB, et al : Opioid analgesics. Goodman and Gilman's the Pharmacological Basis of Therapeutics, 11th ed, The Mcgraw Hill Co, China, 547-590, 2006
 
3) Peng PW, et al : A review of the use of fentanyl analgesia in the management of acute pain in adults. Anesthesiology 90 : 576-599, 1999
PubMed
4) Labroo RB, et al : Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4 : implication for interindividual variability in disposition, efficacy, and drug interactions. Drug Metab Disp 25 : 1072-1080, 1997
 
5) Dean M : Opioids in renal failure and dialysis patients. J Pain Symptom Manage 28 : 497-504, 2004
PubMed
6) Finnerup NB, et al : Algorithm for neuropathic pain treatment : an evidence based proposal. Pain 118 : 289-305, 2005
PubMed
7) 花岡一雄ほか : 強オピオイドによるがん疼痛治療の実際-薬理と臨床の最前線から-. ペインクリニック 27 : 1345-1353, 2006
 
8) 成田年ほか : オピオイドによる消化管障害および鎮痛耐性に関する最新メカニズムの解釈. ペインクリニック 29 : 356-370, 2008
 
9) Radbruch L, et al : Transdermal fentanyl for the management of cancer pain : a survey of 1005 patients. Palliat Med 15 : 309-321, 2001
PubMed
10) 新城拓也ほか : フェンタニル貼付剤の増量に反応しないがん性疼痛に対する経口モルヒネへのオピオイドローテーション. Palliat Care Res 2 : 306-309, 2007
 
P.142 掲載の参考文献
1) Jaffe JH, et al : The Pharmacological Basis of Therapeutics, Gilman AG, et al eds, 8th ed, Pergman Press, Tokyo, 485-521, 1990
 
2) 加藤実ほか : リン酸コデイン. ペインクリニック 20 : 413-416, 1999
 
3) 鈴木孝浩 : がん性疼痛管理 IV がん性疼痛の薬物療法
 
3. リン酸コデインを上手に使う. ペインクリニック 27 : S55-S58, 2006
 
4) Laudico AV : The Philippines status of cancer pain and palliative care. J Pain Sympt Manage 8 : 429-430, 1993
 
5) Arkinstall W, et al : Efficacy of controlled-release codeine in chronic non-malignant pain : a randomized, placebocontrolled clinical trial. Pain 62 : 169-178, 1995
 
6) Stanbaugh JE, et al : comparison of the analgesic efficacy and safety of oral ciramadol, codeine, and placebo in patients with chronic cancer pain. J Clin Pharmacol 27 : 162-169, 1987
 
7) 白土辰子ほか : 癌疼痛療法の進歩 弱オピオイド鎮痛薬. 日本臨牀 59 : 1795-1799, 2001
 
8) 太田孝一 : 弱オピオイド製剤 リン酸コデイン. オピオイド, 並木昭義ほか監修, 克誠堂出版, 東京, 82-83, 2005
 
P.145 掲載の参考文献
1) Collins VJ : Opiate and narcotic drugs. Physiologic and Pharmacologic Bases of Anesthesia, Collins VJ ed, Williams & Wilkins, Baltimore, 544-581, 1996 (権威者の意見, 記述疫学)
 
2) Stoelting RK : Pharmacology and Physiology in Anesthetic Practice, 3rd ed, Lippincott-Raven, Philadelphia, 77-112, 1999 (権威者の意見, 記述疫学)
 
3) De Castro JM, et al : Regional Opioid Analgesia. Kluwer Academic Publishers, Dordrecht, 139-144, 1991 (権威者の意見, 記述疫学)
 
4) Steward DJ : Preoperative evaluation and preparation for surgery. Pediatric Anesthesia, Gregory GA ed, 3rd ed, Churchill Livingstone, New York, 179-196, 1994 (権威者の意見, 記述疫学)
 
5) Ngan Kee WD : Intrathecal pethidine : pharmacology and clinical applications. Anaesth Intensive Care 26 : 137-146, 1998 (ランダム化比較試験)
 
6) Ngan Kee WD : Epidural pethidine : pharmacology and clinical experience. Anaesth Intensive Care 26 : 247-255, 1998 (ランダム化比較試験)
 
7) Reisine T, et al : Opioid analgesics and antagonists. Goodman and Gilman's The Pharmacological Basis of Therapeutics, Hardman JG, et al eds, 9th ed, McGraw-Hill, New York, 521-556, 2001 (権威者の意見, 記述疫学)
 
P.148 掲載の参考文献
1) Nicholson A, et al : Methadone for cancer pain protocol. Cochrane Database System Rev 2 : CD003971, 2004
 
2) Shimoyama N, et al : D-methadone is anti-nociceptive in the rat formalin test. J Pharmacol Exp Ther 283 : 648-652, 1997
 
3) メサペイン錠(R) 医薬品インタビューフォーム (http://www.info.pmda.go.jp/)
 
4) Garrido MJ, et al : Methadone : a review of its pharmacokinetic/pharmacodynamic properties. J Pharmacol Toxicol Methods 42 : 61-66, 1999
PubMed
5) Eap CB, et al : Interindividual variability of the clinical pharmacokinetics of methadone. Clin Pharmacol 41 : 1153-1193, 2002
 
P.151 掲載の参考文献
1) 高橋秀則 : IV. がん性疼痛の薬物療法, 4. オピオイド受容体拮抗性鎮痛薬. ペインクリニック 27 : s59-s66, 2006
 
2) 日本緩和医療学会緩和医療ガイドライン作成委員会 : II章 背景知識, 4. 薬理学的知識, (2) オピオイド. がん疼痛 の薬物療法に関するガイドライン2010年版, 金原出版, 東京, 35-37, 2010
 
3) 武田弘志ほか : 第VI章, 5. その他のオピオイド. 臨床緩和医療薬学, 日本緩和医療薬学会編, 真興交易医書出版部, 東京, 2008
 
4) 山口重樹ほか : 新しいオピオイド鎮痛薬. ペインクリニック 33 : 701-714, 2012
Medical*Online
P.153 掲載の参考文献
1) 越智元郎ほか : ペンタゾシン依存症が疑われる患者への対応. 治療 84 : s1058-s1061, 2002
 
2) 鈴木勉 : 鎮痛薬 "中毒" (アスピリンやペンタゾシン). ペインクリニック 24 : 1663-1668, 2003
 
3) 塩酸ペンタゾシン錠「ソセゴン(R) 錠25mg」添付文書
 
4) ペンタゾシン注射液「ソセゴン(R) 注射液15mg」添付文書
 
P.158 掲載の参考文献
1) Heel RC, et al : Buprenorphine : a review of its pharmacological properties and therapeutic efficacy. Drugs 17 : 81-110, 1979
PubMed
2) 松本真希ほか : 慢性疼痛におけるブプレノルフィン. ペインクリニック 20 : 1127-1133, 1999
 
3) Health Care Guideline Institute for Clinical Systems Improvement (ICSI) : Assessment and Management of Chronic Pain, 3rd ed, Health Care Guideline, 1-74, 2008
 
4) 小川節郎 : ブプレノルフィン経皮吸収型製剤 (ノルスパンテープ). ペインクリニック 32 : 1907-1910, 2012
 
5) 濱口眞輔 : 運動器慢性疼痛とオピオイド鎮痛剤による治療の実際. Pharma Medica 30 : 60-64, 2012
Medical*Online
6) Landau CJ, et al : Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy : a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study. Clin Ther 29 : 2179-2193, 2007
PubMed
7) Loeser JD, et al : The Kyoto protocol of IASP basic pain terminology. Pain 137 : 473-477, 2008
PubMed
8) 濱口眞輔ほか : ブプレノルフィン (坐剤・舌下錠・貼付薬). ペインクリニック (別冊秋号) 33 : S443-S453, 2012
 
9) Wolff RF, et al : Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain. Curr Med Res Opin 28 : 833-845, 2012
PubMed
10) Gowing L, et al : Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev 3, CD002025, 2009
PubMed
P.160 掲載の参考文献
1) 岡部達士郎ほか : 癌性疼痛に対するエプタゾシン長期投与例-耐性および依存性の観察-. 薬理と治療 10 : 6039-6044, 1982
 
2) 遠藤正臣ほか : 癌性疼痛患者におけるEptazocineの依存性と薬剤耐性の観察. 薬理と治療 10 : 6485-6498, 1982
Medical*Online
3) 鍋島俊隆ほか : Eptazocine (1-1, 4-dimethyl-10-hydroxy-2, 3, 4, 5, 6, 7-hexahydro-1, 6-methano-1H-4-benzazonine) の薬理作用. 日薬理誌 87 : 619-627, 1986
Medical*Online
4) 相田純久 : 硬膜外鎮痛法をκ作動薬とNMDA 拮抗薬から考える-鎮痛機序の考察と仮説-. 日臨麻会誌 28 : 204-216, 2008
 
P.164 掲載の参考文献
1) 山口重樹ほか : 新しいオピオイド鎮痛薬. ペインクリニック 33 : 701-714, 2012
Medical*Online
2) トラマドール塩酸塩「トラマール(R) カプセル」添付文書
 
3) トラマドール塩酸塩製剤「トラマール(R) 注100」添付文書
 
4) トラマドール塩酸塩/ アセトアミノフェン配合錠「トラムセット(R) 配合錠」添付文書
 
5) Mullican WS, et al : Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain : a comparative trial. Clin Ther 23 : 1429-1445, 2001
PubMed
6) Reig E : Tramadol in musculoskeletal pain-a survey. Cln Rheumatol 21 : S9-S11, 2002
 
7) Boyer EW, et al : The serotonin syndrome. N Engl J Med 352 : 1112-1120, 2005
PubMed
8) Poulsen L, et al : The hypoalgesic effect of tramadol in relation to CYP2D6. Clin Pharmacol Ther 60 : 636-644, 1996
PubMed
P.168 掲載の参考文献
1) Vane JR : Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231 : 232-235, 1971
PubMed
2) Kujubu DA, et al : TIS10, a phorbol ester tumor promoterinducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266 : 12866-12872, 1991
PubMed
3) Pairet M, et al : Distinct isoforms (COX-1 and COX-2) of cyclooxygenase : possible physiological and therapeutic implications. Fundam Clin Pharmacol 10 : 1-17, 1996
PubMed
4) Donnelly MT, et al : COX-II inhibitors - a new generation of safer NSAIDs? Aliment Pharmacol Ther 11 : 227-236, 1997
 
5) Yamamoto T, et al : Role of cyclooxygenase (COX) -1 and COX-2 in nociceptive transmission in the rat formalin test. Anesth Analg 94 : 962-967, 2002
PubMed
6) Yamamoto T, et al : Anti-allodynic effects of oral COX-2 selective inhibitor on postoperative pain in the rat. Can J Anaesth 7 : 354-360, 2000
 
7) Saito O, et al : Analgesic effects of non-steroidal antiinflammatory drugs, acetaminophen, and morphine in a mouse model of bone cancer pain. J Anesth 19 : 218-224, 2005
 
8) Willingale HL, et al : Prostanoids synthesized by cyclooxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability. Br J Pharmacol 122 : 1593-1604, 1997
 
P.173 掲載の参考文献
1) Kato M, et al : Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs : investigation using human peripheral monocytes. J Pharm Pharmacol 53 : 1679-1685, 2001
PubMed
2) Ong CKS, et al : An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res 5 : 19-34, 2007
 
3) Edwards JE, et al : Oral aspirin in postoperative pain : quantitative systematic review. Pain 81 : 289-297, 1999
PubMed
4) Mason L, et al : Single dose oral indomethacin for the treatment of acute postoperative pain. Cochrane Database Syst Rev 2004 : CD004308. 2004
PubMed
5) Mason L, et al : Single dose oral naproxen and naproxen sodium for acute postoperative pain. Cochrane Database Syst Rev 2004 : CD004234. 2004
PubMed
6) Bur ton ME, et al : Appl ied Pharmacokinet ics & Pharmacodynamics Principle of Therapeutic Drug Monitoring, 4th ed, Lippincott Williams & Wilkins, Philadelphia, 753-756, 2006
 
7) Wolfe MM, et al : Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340 : 1888-1899, 1999
PubMed
8) Kato M, et al : Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury : a randomized, doubleblinded, placebo controlled study. J Gastroenterol Hepatol 25 : 1631-1635, 2010
PubMed
9) Wallace JL, et al : Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology 141 : 1314-1322, 2011
 
10) Fiorucci S, et al : Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 129 : 1210-1224, 2005
PubMed
P.176 掲載の参考文献
1) Sakamoto C, et al : Comparison of gastroduodenal ulcer incidence in healthy Japanese subjects taking celecoxib or loxoprofen evaluated by endoscopy : a placebo-controlled, double-blind 2-week study. Aliment Pharmacol Ther 37 : 346-354, 2013
PubMed
2) Tirunagari SK, et al : Single dose oral etodolac for acute postoperative pain in adults. Cochrane Database Syst Rev 8 : 2009, CD007357
PubMed
3) 安倍達ほか : 関節リウマチに対するセレコキシブ (YM177) の臨床評価-ロキソプロフェンナトリウムを対照とした第III相二重盲検並行群間比較試験-. Prog Med 26 : 2820-2845, 2006
Medical*Online
4) Emery P, et al : Celecoxib versus diclofenac in long-term management of rheumatoid arthritis : randomised doubleblind comparison. Lancet 354 : 2106-2111, 1999
PubMed
5) Chen YF, et al : Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoar thritis and rheumatoid ar thritis : a systematic review and economic evaluation. Health Technol Assess 12 : 1-278, iii, 2008
 
6) McGettigan P, et al : Cardiovascular risk and inhibition of cyclooxygenase : a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 296 : 1633-1644, 2006
PubMed
P.180 掲載の参考文献
1) Hogenstatt ED, et al : Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem 280 : 31405-31412, 2005
 
2) Pickering G, et al : Analgesic effect of acetaminophen in humans : first evidence of central serotonergic mechanism. Clin Pharmacol Ther 79 : 371-378, 2006
PubMed
3) Mallet C, et al : Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain 139 : 190-200, 2008
PubMed
4) Mallet C, et al : TRIPV1 in brain is involved in acetaminophen- induced antinociception. PLoS One 5 : 1-11, 2010
PubMed
5) Ruggieri V, et al : Differential involvement of opioidergic and serotonergic systems in the antinociceptive activity of N-ara-chidonoyl-phenolamine (AM404) in the rat : comparison with paracetamol. Naunyn-Schmiedeberg's Arch Phramacol 377 : 219-229, 2008
 
6) Grossert T, et al : Para-aminophenol derivatives : Acetaminophen. The Pharmacological Basis of Therapeutics, Brunton L, et al eds, 12th ed, McGraw-Hill Professional, 983, 2011
 
7) Lewis SC, et al : Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleedings : a meta-analysis based on individual patient data. Br J Clin Pharmacol 54 : 320-326, 2002
PubMed
8) Benson GD, et al : The therapeutic use of acetaminophen in patients with liver disease. Am J Ther 12 : 133-141, 2005
PubMed
9) Schnitzer TJ : Update of ACR guidelines for osteoarthritis : role of the coxibs. J Pain Symptom Manage 23 : S24-S30, 2002
PubMed
10) Verkleij SP, et al : NSAIDs vs acetaminophen in knee and hip osteoarthritis : A systematic review regarding heterogeneity influencing the outcomes. Osteoarthritis Cartilage 19 : 921-929, 2011
 
11) Chou R, et al : Medications for acute and chronic low back pain : a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 147 : 505-514, 2007
PubMed
12) Ong CKS, et al : Combining paracetamol (acetaminophen) with nonsteroidal anti-inflammatory drugs : a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg 110 : 1170-1179, 2010
PubMed
13) Maund E, et al : Raracetamol and selective and non-selective non-steroidal anti-inflammatory drugs for the reduction in morphine-related side-ef fects after major surgery : a systematic review. Bri J Anaes 106 : 292-297, 2011
 
14) American geriatrics society panel on the pharmacological management of persistent pain in older persons : Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 57 : 1331-1346, 2009
 
P.184 掲載の参考文献
1) 笠山宗正 : 合成グルココルチコイド. 日本臨牀 66 : 119-124, 2008
Medical*Online
2) 笠山宗正 : 抗炎症作用機序. 綜合臨牀 54 : 1968-1974, 2005
Medical*Online
3) 名和田新 : グルココルチコイドレセプター (GR) の作用機序. 炎症と免疫 11 : 631-635, 2003
Medical*Online
4) 大内和雄 : Glucocorticoid の作用機序. 呼吸 16 : 1043-1049, 1997
Medical*Online
5) Hafezi-Moghadam A, et al : Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8 : 473-479, 2002
PubMed
6) 大澤仲昭ほか : 注射剤. 新・副腎皮質ステロイド剤の作用と使い方, ライフサイエンス・メディカ, 東京, 21-23, 1994
 
7) Esteban NV, et al : Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 72 : 39-45, 1991
PubMed
8) 赤真秀人 : ステロイドの話題-関節リウマチ治療を中心として-. 日臨免疫会誌 34 : 464-475, 2011
 
9) Buttgereit F, et al : Standardised nomenclature for glucocorticoid dosages and glucocor ticoid treatment regimens : current questions and tentative answers in rheumatology. Ann Rheum Dis 61 : 718-722, 2002
 
10) Eo WK, et al : Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma : a case report. Ann Hematol 89 : 421-422, 2010
PubMed
11) 市川陽一ほか : グルココルチコイドの副作用. 炎症と免疫 2 : 286-292, 1994
Medical*Online
12) Chang DJ, et al : Reduction in transforming growth factor beta receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid. J Biol Chem 273 : 4892-4896, 1998
 
13) Weinstein RS, et al : Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 109 : 1041-1048, 2002
PubMed
P.189 掲載の参考文献
1) 有田英子ほか : NMDA受容体拮抗薬 (塩酸ケタミン, 臭化水素酸デキストロメトルファン). ペインクリニックで用いる薬100+α, 小川節郎編, 真興交易医書出版部, 東京, 138-148, 2002
 
2) 有田英子ほか : ケタミンカプセル. ペインクリニック 20 : 747-750, 1999
 
3) Clements JA, et al : Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharmaceutical Sci 71 : 539-541, 1982
 
4) Nimmo WS, et al : Ketamine. Pharmacokinetics of Anaesthesia, Prys-Roberts C, et al eds, Blackwell Scientific Publications, 235-245, 1984
 
5) 有田英子ほか : ケタミンの経口投与法の実際. ペインクリニック 24 : 500-507, 2003
 
6) Kato J, et al : Pharmacological tests in 100 patients with intractable pain. Pain Res 14 : 89-95, 1999
 
7) Belozertseva IV, et al : Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice. Naunyn-Schmiedeberg's Arch Pharmacol 358 : 270-274, 1998
PubMed
8) Bowdle TA, et al : Psychedelic ef fects of ketamine in healthy volunteers. Anesthesiology 88 : 82-88, 1998
 
9) Johnson M : The prevention of ketamine dreams. Anaesth Intens Care 1 : 70-74, 1972
 
10) Weiner AL, et al : Ketamine abusers presenting to the emergency department : a case series. J Emerg Med 18 : 447-451, 2000
 
P.192 掲載の参考文献
1) Tytgat GN : Hyoscine butylbromide : A review of its use in the treatment of abdominal cramping and pain. Drugs 67 : 1343-1357, 2007
PubMed
2) Mueller-Lissner S, et al : Placebo-and paracetamolcontrolled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain. Aliment Pharmacol Ther 23 : 1741-1748, 2006
 
3) Holdgate A, et al : Is there a role for antimuscarinics in renal colic? A randomized controlled trial. J Urol 174 : 572-575, 2005
 
4) Song SW, et al : Butylscopolammonium bromide does not provide additional analgesia when combined with morphine and ketorolac for acute renal colic. Emerg Med Australas 24 : 144-150, 2012
 
5) de Brouwer EJ, et al : Hyoscine N-butylbromide does not improve polyp detection during colonoscopy : a doubleblind, randomized, placebo-controlled, clinical trial. Gastrointest Endosc 75 : 835-840, 2012
 
6) Yoong KY, et al : Intravenous hyoscine as a premedication for colonoscopy : a randomized double-blind controlled trial. Endoscopy 36 : 720-722, 2004
PubMed
P.195 掲載の参考文献
1) Okazaki R, et al : The antiallodynic effect of Neurotropin is mediated via activation of descending inhibitory systems in rats with spinal nerve ligation. Anesth Analg 107 : 1064-1069, 2008
PubMed
2) Suzuki T, et al : The antiallodynic and antihyperalgesic effects of neurotropin in mice with spinal nerve ligation. Anesth Analg 101 : 793-799, 2005
PubMed
3) Toda K, et al : Antinocieptive effects of neurotropin in a rat model of painful peripheral mononeuropathy. Life Sci 62 : 913-921, 1998
 
4) Saleh MR, et al : Effects of neurotropin on hyeralgesia and allodynia in mononeuropathic rats. Life Sci 64 : 1931-1938, 1998
 
5) Miura T, et al : Mechanisms of analgesic action of neurotropin on chronic pain in adjuvant-induced arthritic rat : toles of descending noradrenergic and serotonergic systems. J Pharmacol Sci 97 : 429-436, 2005
 
6) Kawashiri T, et al : Neurotropin reverses paclitaxelinduced neuropathy without affecting anti-tumor efficacy. Eur J Cancer 45 : 154-163, 2009
PubMed
7) Kawashiri T, et al : Prevention of oxaliplatin-induced mechanical allodynia and neurodegeneration by neurotropin in the rat model. Eur J Pain 15 : 344-350, 2010
PubMed
8) Kudo T, et al : Antinociceptive effects of neurotropin in a rat model of central neuropathic pain : DSP-4 induced noradrenergic lesion. Neurosci Lett 503 : 20-22, 2011
 
9) Imai Y, et al : Inhiition of the release of bradykinin-like substances into the perfusate of rat hind paw by neurotropin. Jpn J Pharmacol 36 : 104-106, 1984
 
10) Ohara H, et al : Release of inflammatory mediators by noxious stimuli : effect od neurotropin on the release. Eur J Pharmacol 157 : 93-99, 1988
 
11) Ono K : Clinical evaluation of neurotropin tablet in lumbago by a double-blind placebo study. J Pharmacol Ther 9 : 299-307, 1981
 
12) Tsuyama N, et al : Therapeutic effects of Neurotropin on symptomatic neuralgia and low back pain : a double-blind clinical study. Clin Rep 11 : 309-320, 1977
 
13) Momose T : Management of postoperative pain with neurotropin-comparative study using double-blind technique with a combined use of pentazocine injections. J New Remed Clin 28 : 487-493, 1979
 
14) Toda K, et al : Efficacy of neurotropin in fibromyalgia : a case report. Pain Med 9 : 460-463, 2008
PubMed
15) Inagaki M, et al : Relief of chronic burning pain in Fabry disease with neurotropin. Pediatr Neurol 6 : 211-213, 1990
PubMed
16) Okada M, et al : Complex regional pain syndrome type I induced by pacemaker implantation, with a good response to steroid and neurotropin. Intern Med 41 : 498-501, 2002
PubMed
P.199 掲載の参考文献
1) Baldwin MR, et al : Association of botulinum neurotoxins with synaptic vesicle protein complexes. Toxicon 54 : 570-574, 2009
PubMed
2) Pavone F, et al : Botulinum neurotoxin for pain management : insights from animal pain models. Toxins 2 : 2890-2913, 2010
PubMed
3) Cui M, et al : Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 107 : 125-133, 2004
PubMed
4) Bach-Rojecky L, et al : Botlinum toxin type A in experimental neuropathic pain. J Neural Transm 112 : 215-219, 2005
 
5) Park HJ, et al : The ef fects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain. Can J Anaesth 53 : 470-477, 2006
 
6) Marinelli S, et al : Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery af ter per ipheral ner ve injury in animal models. Neuroscience 171 : 316-328, 2010
 
7) Wiegand H, et al : 125I-labelled botulinum A neurotoxin : pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol 292 : 161-165, 1976
PubMed
8) Marinelli S, et al : The analgesic effect on neuropathic pain of retrogradely transpor ted botulinum neurotoxin A involves Schwann cells and astrocytes. PLos ONE 7 : 1-12, 2012
 
9) Kitamura Y, et al : Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction. Neuroscience 159 : 1422-1429, 2009
PubMed
10) Bach-Rojecky L, et al : Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy : bilateral effect after unilateral injection. Eur J Pharmacol 633 : 10-14, 2010
PubMed
11) Jabbari B : Evidence based medicine in the use of botulinum toxin for back pain. J Neural Transm 115 : 637-640, 2008
PubMed
12) Zhang T, et al : The efficacy of botulinm toxin type A in managing chronic muscloskeletal pain : a systemic review and meta analysis. Inflammopharmacology 19 : 21-34, 2011
 
13) Emad MR, et al : The efficacy of intradermal injection of botulinum toxin in patients with post-herpetic neuralgia. Iran Red Crescent Med J 13 : 323-327, 2011
PubMed
14) Gobel H, et al : Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes. Pain 91 : 195-199, 2001
PubMed
15) Ashkenazi A : Botulinum toxin type a for chronic migrane. Curr Neurol Neurosci Rep 10 : 140-146, 2010
 
16) Porta M, et al : The rationale and results of treating muscle spasm and myofascial syndromes with botulinum toxin type A. Pain Digest 8 : 346-352, 1998
 
P.206 掲載の参考文献
1) 高木嘉子 : 治打撲一方の圧痛点. 日東洋医会誌 45 : 541-545, 1995
 
2) 平田道彦 : 頭痛に対する漢方治療. ペインクリニック 32 : 645-654, 2011
Medical*Online
3) 平田道彦ほか : 難治性疼痛の漢方治療. ペインクリニック 29 : 299-308, 2008
 
4) 平田道彦ほか : 抑肝散加味方による特発性三叉神経痛の治療について. 痛みと漢方 16 : 103-107, 2006
 
P.210 掲載の参考文献
1) O'Donnell JM, et al : Drug therapy of depression and anxiety disorders. Goodman & Gilman's the Pharmacological Basis of Therapeutics, Brunton LL, et al. eds, 12th ed, The McGraw-Hill Co, New York, 397-415, 2011
 
2) Dworkin RH, et al : Pharmacologic management of neuropathic pain : evidence-based recommendations. Pain 132 : 237-251, 2007
PubMed
3) Attal N, et al : EFNS guidelines on the pharmacological treatment of neuropathic pain : 2010 revision. Eur J Neurol 17 : 1113-1123, 2010
PubMed
4) Graff-Radford SB, et al : Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain 16 : 188-192, 2000.
PubMed
5) 平田和彦ほか : 非急性帯状疱疹患者 (皮疹発症30日以上の帯状疱疹患者) への三環系抗うつ薬増量の効果. 日本ペインクリニック学会誌 19 : 482-489, 2012
Medical*Online
6) Bowsher D : The ef fect of pre-emptive treatment of postherpetic neuralgia with amitriptyline : a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 13 : 327-331, 1997
 
7) Dworkin RH : Prevention of postherpetic neuralgia. Lancet 353 : 1636-1637, 1999
PubMed
8) Dharmshaktu P, et al : Efficacy of antidepressants as analgesics : a review. J Clin Pharmacol 52 : 6-17, 2012
PubMed
9) Finnerup NB, et al : The evidence for pharmacological treatment of neuropathic pain. Pain 150 : 573-581, 2010
PubMed
P.215 掲載の参考文献
1) Bellingham GA, et al : Duloxetine : a review of its pharmacology and use in chronic pain management. Reg Anesth Pain Med 35 : 294-303, 2010
PubMed
2) Sullivan MD, et al : Antidepressant and anticonvulsant medication for chronic pain. Phys Med Rehabil Clin N Am 17 : 381-400, vi-vii, 2006
 
3) Goldstein DJ : Duloxetine in the treatment of major depressive disorder. Neuropsychiatr Dis Treat 3 : 193-209, 2007
PubMed
4) Arnold LM, et al : Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder. Clin J Pain 25 : 461-468, 2009
PubMed
5) Dworkin RH, et al : Pharmacologic management of neuropathic pain : evidence-based recommendations. Pain 132 : 237-251, 2007
PubMed
6) Attal N, et al : EFNS guidelines on the pharmacological treatment of neuropathic pain : 2010 revision. Eur J Neurol 17 : 1113-1123, e67-e88, 2010
 
7) Moulin DE, et al : Pharmacological management of chronic neuropathic pain-consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 12 : 13-21, 2007
PubMed
8) 日本ペインクリニック学会神経障害性疼痛薬物療法ガイドライン作成グループ編 : 神経障害性疼痛薬物療法ガイドライン, 真興交易医学出版部, 東京, 2011
 
9) Skljarevski V, et al : Duloxetine versus placebo in patients with chronic low back pain : a 12-week, fixed-dose, randomized, double-blind trial. J Pain 11 : 1282-1290, 2010
 
10) Chappell AS, et al : A double-blind, randomized, placebocontrolled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Pract 11 : 33-41, 2011
PubMed
11) Takenaka M, et al : Successful treatment by adding duloxetine to pregabalin for peripheral neuropathy induced by paclitaxel. Am J Hosp Palliat Care, 2012 (Epub ahead of print)
 
12) Matsuoka H, et al : Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalin. Anticancer Res 32 : 1805-1809, 2012
PubMed
13) Kaur H, et al : A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy : a randomized, double-blind, cross-over clinical trial. Diabetes Care 34 : 818-822, 2011
PubMed
14) Gaynor P, et al : Weight change with long-term duloxetine use in chronic painful conditions : an analysis of 16 clinical studies. Int J Clin Pract 65 : 341-349, 2011
PubMed
15) 尾鷲登志美ほか : SSRIによるactivation syndromeの定義, 病態, 治療, 予防. 臨精薬理 11 : 1813-1819, 2008
 
16) Spiegel DR, et al : A presumed case of phantom limb pain treated successfully with duloxetine and pregabalin. Gen Hosp Psychiatry 32 : 228. e5-7, 2010
 
17) Kostopanagiotou G, et al : Successful pain relief of cutaneous leiomyomata due to reed syndrome with the combination treatment of pregabalin and duloxetine J Pain Symptom Manage 38 : e3-5, 2009
PubMed
18) Finnerup NB, et al : The evidence for pharmacological treatment of neuropathic pain. Pain 150 : 573-581, 2010
PubMed
19) Vranken JH, et al : Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke : a randomized, double-blind, placebo-controlled trial. Pain 152 : 267-273, 2011
PubMed
P.219 掲載の参考文献
1) Fawcett J, et al : Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patient of patients with major depression. J Affect Disord 51 : 267-285, 1998
PubMed
2) Mico JA, et al : Antidepressants and pain. Trends Pharmacol Sci 27 : 348-354, 2006
PubMed
3) Fienmann C : Pain relief by antidepressants, Possible modes of action. Pain 23 : 1-8, 1985
 
4) Tollison CD : Antidepressant use in patients with chronic pain. Drug Therapy 20 : 50-52, 55-57, 1990
 
5) Ventafridda V, et al : Studies on the effects of antidepressant drugs on the antinociceptive action of morphine and on plasma morphine in rat and man. Pain 43 : 155-162, 1990
PubMed
6) Tsuda M, et al : P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 : 778-783, 2003
PubMed
7) Benfield P, et al : Fluvoxamine, a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32 : 313-334, 1986
PubMed
8) 井上和秀ほか : エコファーマの実際・今後の展開. ペインクリニック 31 : 461-471, 2010
 
9) Zhu J, et al : Repeated administration of mirtazapine inhibits development of mirtazapine inhibits development of hyperalgesia/allidynia and activation of NF-kappa B in a rat model of neuropathic pain. Neurosci Lett 433 : 33-37, 2008
 
10) Finnerup NB, et al : The evidence for pharmacological treatment of neuropathic pain. Pain 150 : 573-581, 2010
PubMed
11) Bendtsen L, et al : EFNS guideline on the treatment of tension-type headache-report of an EFNS task force. Eur J Neurol 17 : 1318-1325, 2010
PubMed
12) Bank J : A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis : A double-blind trial. Headache 34 : 476-478, 1994
 
13) Manna V, et al : Chronic tention-type headache, mood depression and serotonin : Therapeutic effects of fluvoxamine and mianserine. Headache 34 : 44-49, 1994
 
14) Foster CA, et al : paroxetine in the treatment of chronic daily headache. Headache 34 : 587-589, 1994
PubMed
15) Sindrup SH, et al : The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 42 : 135-144, 1990
PubMed
16) Bendtsen L, et al : Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 62 : 1706-1711, 2004
PubMed
17) Moret C, et al : Antidepressants in the treatment of fibromyalgia. Neuropsychiatr Dis Treat 2 : 537-548, 2006
PubMed
18) Samborski W, et al : Open trial of mirtazapine in patients with fibromyalgia. Pharmacopsychiatry 37 : 168-170, 2004
PubMed
19) Sperber AD : Toxic interaction between fluvoxamine and sustained release theophylline in 11-year-old boy. Drug Safety 6 : 460-462, 1991
PubMed
P.225 掲載の参考文献
1) 日本ペインクリニック学会神経障害性疼痛薬物療法ガイドライン作成ワーキンググループ編 : 神経障害性疼痛薬物療法ガイドライン, 真興交易医書出版部, 東京, 20-30, 2011
 
2) Finnerup NB, et al : Algorithm for neuropathic pain treatment : An evidence based proposal. Pain 118 : 289-305, 2005
PubMed
3) Finnerup NB, et al : The evidence for pharmacological treatment of neuropathic pain. Pain 150 : 573-581, 2010
PubMed
4) Attal N, et al : EFNS guidelines on the pharmacological treatment of neuropathic pain : 2010 version. Eur J Neurol 17 : 1113-1123, 2010
 
5) Kochar DK, et al : Divalproex sodium in the management of post-herpetic neuralgia : a randomized double-blind placebo-controlled study. QJM 98 : 29-34, 2005
PubMed
6) Otto M, et al : Valproic acid has no effect on pain in polyneuropathy : a randomized, controlled trial. Neurology 62 : 285-288, 2004
PubMed
7) Goodyear-Smith F, et al : Anticonvulsants for neuropathic pain : gaps in the evidence. Clin J Pain 25 : 528-536, 2009
PubMed
8) Saruwatari J, et al : The clinical impact of cytochrome P450 polumorphisms on anti-epileptic drug therapy. Epilepsy & Seizure 3 : 34-50, 2010
 
9) Tateishi T : Polymorphisms of CYP and ethnic differences. Epilepsy & Seizure 3 : 141-146, 2010
 
10) Bialer M : Why are antiepileptic drugs used for nonepileptic conditions? Epilepsia 53 (suppl 7) : 26-33, 2012
 
P.229 掲載の参考文献
1) Field MJ, et al : Identification of the alpha 2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci USA 103 : 17537-17542, 2006
 
2) Takasusuki T, et al : The effects of intrathecal and systemic gabapentin on spinal substance P release. Anesth Analg 112 : 971-976, 2011
PubMed
3) Hayashida K, et al : Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery. Anesthesiology 106 : 557-562, 2007
PubMed
4) Miyazaki R, et al : The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model. Anesth Analg 115 : 182-188, 2012
PubMed
5) Bockbrader HN, et al : A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet 49 : 661-669, 2010
PubMed
6) Stacey BR, et al : Pregabalin for postherpetic neuralgia : placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. J Pain 9 : 1006-1017, 2008
PubMed
7) Yoo L, et al : Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure. Am J Kidney Dis 54 : 1127-1130, 2009
 
8) Finnerup NB, et al : The evidence for pharmacological treatment of neuropathic pain. Pain 150 : 573-581, 2010
PubMed
9) Brodie MJ, et al : Pregabalin drug interaction studies, Lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. Epilepsia 46 : 1407-1413, 2005
PubMed
10) Luo ZD, et al : Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 303 : 1199-1205, 2002
PubMed
P.235 掲載の参考文献
1) Bartlett EE, et al : Xylocaine for the relief of postoperative pain. Anesth Analg 40 : 296-304, 1961
PubMed
2) Boas RA, et al : Analgesic responses to i.v. lignocaine. Br J Anaesth 54 : 501-505, 1982
 
3) Kawamata M, et al : Effects of systemic administration of lidocaine and QX-314 on hyperexcitability of spinal dorsal horn neurons after incision in the rat. Pain 122 : 68-80, 2006
PubMed
4) Marchettini P, et al : Lidocaine test in neuralgia. Pain 48 : 377-382, 1992
PubMed
5) Attal N, et al : Systemic lidocaine in pain due to peripheral nerve injury and predictors of response. Neurology 62 : 218-225, 2004
PubMed
6) Gottrup H, et al : Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain. Anesthsiology 104 : 527-536, 2006
 
7) Tremont-Lukats IW, et al : A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain. Clin J Pain 22 : 266-271, 2006
PubMed
8) Attal N, et al : Intravenous lidocaine in central pain : a double-blind, placebo-controlled, psychophysical study. Neurology 54 : 564-574, 2000
 
9) Finnerup NB, et al : Intravenous lidocaine relieves spinal cord injury pain : a randomized controlled trial. Anesthesiology 102 : 1023-1033, 2005
 
10) Rowbotham MC, et al : Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 41 : 1024-1028, 1991
PubMed
11) Baranowski AP, et al : A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. J Pain Symptom Manage 17 : 429-433, 1999
PubMed
12) 藤井洋泉ほか : 急性帯状疱疹痛に対するリドカイン全身投与 : プラセボ比較試験. 麻酔 58 : 1413-1417, 2009
Medical*Online
13) 眞鍋治彦ほか : 急性期の帯状疱疹治療. 日臨麻会誌 28 : 2-11, 2008
 
14) Kastrup J, et al : Intravenous lidocaine infusion-a new treatment of chronic painful diabetic neuropathy? Pain 28 : 69-75, 1987
PubMed
15) Galer BS, et al : Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine. J Pain Symptom Manage 12 : 161-167, 1996
PubMed
16) Cassuto J, et al : Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine. Anesth Analg 64 : 971-974, 1985
PubMed
17) Groudine SB, et al : Intravenous lidocaine speeds the return of bowel function, decreases postoperative pain, and shortens hospital stay in patients undergoing radical retropubic prostatectomy. Anesth Analg 86 : 235-239, 1998
PubMed
18) Koppert W, et al : Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg 98 : 1050-1055, 2004
PubMed
19) Kaba A, et al : Intravenous lidocaine infusion facilitates acute rehabilitation after laparoscopic colectomy. Anesthesiology 106 : 168-172, 2007
 
20) Cepeda MS, et al : Equivalent outcomes during postoperative patient-controlled intravenous analgesia with lidocaine plus morphine versus morphine alone. Anesth Analg 83 : 102-106, 1996
PubMed
21) Sharma S, et al : A phase II pilot study to evaluate use of intravenous lidocaine for opioid-refractory pain in cancer patients. J Pain Symptom Manage 37 : 85-93, 2009
 
22) Ellemann K, et al : Trial of intravenous lidocaine on painful neuropathy in cancer patients. Clin J Pain 5 : 291-294, 1989
PubMed
23) Bruera E, et al : A randomized double-blind crossover trial of intravenous lidocaine in the treatment of neuropathic cancer pain. J Pain Symptom Manage 7 : 138-140, 1992
PubMed
24) Nozaki-Taguchi N, et al : Vincristine-induced allodynia in the rat. Pain 93 : 69-76, 2001
PubMed
25) Wu CL, et al : Analgesic effects of intravenous lidocaine and morphine on postamputation pain : a randomized, double-blind, active placebo-controlled, crossover trial. Anesthesiology 96 : 841-848, 2002
 
26) Chabal C, et al : The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology 76 : 513-517, 1992
PubMed
27) Wallace MS, et al : Efficacy of oral mexiletine for neuropathic pain with allodynia. Reg Anesth Pain Med 25 : 459-467, 2000
PubMed
28) Chiou-Tan FY, et al : Effect of mexiletine on spinal cord injury dysesthetic pain. Am J Phys Med Rehabil 75 : 84-87, 1996
PubMed
29) Dejgard A, et al : Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 9 : 1 (8575-6) : 9-11, 1988
 
30) Stracke H, et al : Mexiletine in the treatment of diabetic neuropathy. Diabetes Care 15 : 1550-1555, 1992
PubMed
31) Oskarsson P, et al : Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. Diabetes Care 20 : 1594-1597, 1997.
PubMed
32) Fassoulaki A, et al : The analgesic effect of gabapentine and mexiletine after breast surgery for cancer. Anesth Analg 95 : 985-991, 2002
PubMed
33) 長櫓巧ほか : ニューロパシックペインに対するメキシレチン経口投与の有効性に及ぼす諸因子の検討-多変量解析 (数量化II類) による-. ペインクリニック 18 : 637-641, 1997
 
P.237 掲載の参考文献
1) Stix, G : Molecular treasure hunt. Sci Am 292 : 88-93, 2005
PubMed
2) Schmidtko A, et al : Ziconotide for treatment of severe chronic pain. Lancet 375 : 1569-1577, 2010
PubMed
3) Cizkova D, et al : Localization of N-type Ca2+ channels in the rat spinal cord following chronic constrictive nerve injury. Exp Brain Res 147 : 456-463, 2002
 
4) Wallace MS : Ziconotide : a new nonopioid intrathecal analgesic for the treatment of chronic pain. Expert Rev Neurother 6 : 1423-1428, 2006
PubMed
5) Staats PS, et al : Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS : a randomized controlled trial. JAMA 291 : 63-70, 2004
PubMed
6) Wallace MS, et al, for the Ziconotide Nonmalignant Pain Study 96-002 Group : Intrathecal ziconotide in the treatment of chronic nonmalignant pain : a randomized, doubleblind, placebo-controlled clinical trial. Neuromodulation 9 : 75-86, 2006
 
7) Rauck RL et al, and the Ziconotide 301 Study Group : A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage 31 : 393-406, 2006
 
8) Snutch TP : Targeting chronic and neuropathic pain : the N-type calcium channel comes of age. Neuro Rx 2 : 662-670, 2005
 
9) Yamamoto T, et al : Recent updates of N-type calcium channel blockers with therapeutic potential for neuropathic pain and stroke. Curr Top Med Chem 9 : 377-395, 2009
 
P.247 掲載の参考文献
1) Brennan TJ, et al : Characterization of a rat model of incisional pain. Pain 64 : 493-501, 1996
PubMed
2) Kawamata M, et al : Experimental incision-induced pain in human skin : effects of systemic lidocaine on flare formation and hyperalgesia. Pain 100 : 77-89, 2002
PubMed
3) Woolf CJ, et al : Preemptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 77 : 362-379, 1993
PubMed
4) Pogatzki EM, et al : Characterization of A delta -and C-fibers innervating the plantar rat hindpaw one day after an incision. J Neurophysiol 87 : 721-731, 2002
 
5) Fimer I, et al : Modality-specific somatosensory changes in a human sur rogate model of postoperative pain. Anesthesiology 115 : 387-397, 2011
 
6) Xu J, et al : Comparison of skin incision vs. skin plus deep tissue incision on ongoing pain and spontaneous activity in dorsal horn neurons. Pain 144 : 329-339, 2009
PubMed
7) Elia N, et al : Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Metaanalyses of randomized trials. Anesthesiology 103 : 1296-304, 2005
PubMed
8) Korpela R, et al : Morphine-sparing effect of acetaminophen in pediatric day-case surgery. Anesthesiology 91 : 442-447, 1999
PubMed
9) Hayashida M, et al : Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype. Pharmacogenomics 9 : 1605-1616, 2008
PubMed
10) Hudcova J, et al : Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain. Cochrane Database Syst Rev 18 : CD003348, 2006
 
11) 高橋正裕ほか : POPS研究会による全国アンケート調査の結果報告-腹部手術後の術後鎮痛に関する調査結果. 日臨麻会誌 31 : 952-958, 2011
 
12) Block BM, et al : Efficacy of postoperative epidural analgesia : a meta-analysis. JAMA 290 : 2455-2463, 2003
PubMed
13) Loper KA, et al : Epidural and intravenous fentanyl infusion are clinically equivalent after knee surgery. Anesth Analg 70 : 72-75, 1990
PubMed
14) Hurley RW, et al : Acute postoperative pain. Miller's Anesthesia, 7th ed, Churchill Livingstone, Philadelphia, 2757-2841, 2009
 
15) Zhang J, et al : Efficacy of pregabalin in acute postoperative pain : a meta-analysis. Br J Anaesth 106 : 454-462, 2011
PubMed
16) Berde CB, et al : Local anesthetics. Miller's Anesthesia, 7th ed, Churchill, Livingstone, Philadelphia, 913-939, 2009
 
17) Liu SS, et al : The effect of analgesic technique on postoperative patient-reported outcomes including analgesia : a systematic review. Anesth Analg 105 : 789-808, 2007
PubMed
18) Wu CL, et al : Treatment of acute postoperative pain. Lancet 377 : 2215-2225, 2011
PubMed
19) Bonica JJ : Postoperative pain. The Management of Pain, 2nd ed, Lea and Febiger, Philadelphia, 461-480, 1990
 
20) PROSPECT. http://www.postoppain.org/frameset.htm
 
21) White PF, et al : Improving postoperative pain management : what are the unresolved issues? Anesthesiology 112 : 220-225, 2010
PubMed
22) Joshi GP, et al : Evidence-based postoperative pain management after laparoscopic colorectal surgery. Colorectal Dis 15 : 146-155, 2013
PubMed
23) Joshi GP, et al : A systematic review of randomized trials evaluating regional techniques for postthoracotomy analgesia. Anesth Analg 107 : 1026-1040, 2008
PubMed
24) Fischer HB, et al : A procedure-specific systematic review and consensus recommendations for postoperative analgesia following total knee arthroplasty. Anaesthesia 63 : 1105-1123, 2008
PubMed
25) Ong CK, et al : The efficacy of preemptive analgesia for acute postoperative pain management : a meta-analysis. Anesth Analg 100 : 757-773, 2005
PubMed
26) Ip HY, et al : Predictors of postoperative pain and analgesic consumption : a qualitative systematic review. Anesthesiology 111 : 657-677, 2009
PubMed
P.251 掲載の参考文献
1) Schug SA, et al : Cancer pain management according to WHO analgesic guidelines. J Pain Symptom Manage 5 : 27-32, 1990
PubMed
2) 川股知之 : がん性疼痛. ペインクリニック別冊 がん疼痛管理に必要な知識, 小川節郎編, 真興交易医書出版部, 東京, s14-s25, 2010
 
3) Kerba M, et al : Neuropathic pain features in patients with bone metastasis referred for palliative radiotherapy. J Clin Oncol 33 : 4892-4897, 2010
 
4) Yamamoto J, et al : Change in μ opioid receptor expression in DRG and spinal cord in a murine model of bone cancer pain. Neuroscience 151 : 65-72, 2008
 
5) Luger NM, et al : Osteoprotegerin diminishes advanced bone cancer pain. Cancer Res 61 : 4038-4047, 2001
PubMed
6) Wong R, et al : Bisphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev 2 : CD002068, 2002
PubMed
7) Saad F, et al : Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer. Urology 76 : 1175-1181, 2010
PubMed
8) Huang WW, et al : Zoledronic acid as an adjuvant therapy in patients with breast cancer : A systematic review and meta-analysis. PLos One 7 : e40783, 2012
PubMed
9) Cleeland CS, et al : Pain outcomes in patients with advanced breast cancer and bone metastases : Results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer 119 : 832-838, 2013
PubMed
10) Tannock I, et al : Treatment of metastatic prostatic cancer with low-dose prednisone : evaluation of pain and quality of life as pragmatic indices of response. J Clin Oncol 7 : 590-597, 1989
PubMed
P.255 掲載の参考文献
1) Bennett MI, et al : Prevalence and etiology of neuropathic pain in cancer patients : A systemic review. Pain 153 : 359-365, 2012
 
2) Shimoyama M, et al : A mouse model of neuropathic cancer pain. Pain 99 : 167-174, 2002
PubMed
3) Shimoyama M, et al : Change of dorsal horn neurochemistry in a mouse model of neuropathic pain. Pain 114 : 221-230, 2005
 
4) Caraceni A, et al : Gabapentin for neuropathic cancer pain : a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 22 : 2909-2917, 2004
 
5) Keskinbora K, et al : Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain : A randomized open trial. J Pain Symptom Manage 34 : 183-189, 2007
 
6) Mercadante S, et al : Amitriptyline in neuropathic cancer pain in patients on morphine therapy : a randomized placebo-controlled, double-blind crossover study. Tumori 88 : 239-242, 2002
PubMed
7) Arai YC, et al : Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine. J Anesth 24 : 407-410, 2010
PubMed
8) Mercadante S, et al : Analgesic ef fect of intravenous ketamine in cancer patients on morphine therapy : a randomized, controlled, double-blind, crossover, doubledose study. J Pain Symptom Manage 20 : 246-252, 2000
 
9) Hardy J, et al : Randomized, double-blind, placebcontrolled study to assess the ef ficacy and toxicity of subcutaneous ketamine in the management of cancer pain. J Clin Oncol 30 : 3611-3617, 2012
 
10) Ellemann K, et al : Trial of intravenous lidocaine on painful neuropathy in cancer patients. Clin J Pain 5 : 291-294, 1989
PubMed
11) Bruera E, et al : A randomized double-blind crossover trial of intravenous lidocaine in the treatment of neuropathic pain. J Pain Symptom Manage 7 : 138-140, 1992
PubMed
12) Kurita GP, et al : How is neuropathic cancer pain assessed in randomized controlled trials? Pain 153 : 13-17, 2012
 
13) Treede RD, et al : Neuropathic pain. Neurology 70 : 1630-1635, 2008
PubMed
P.259 掲載の参考文献
1) Paice JA : Chronic treatment-related pain in cancer survivors. Pain 152 : S84-S89, 2011
PubMed
2) Wang XM, et al : Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine 59 : 3-9, 2012
PubMed
3) Argyriou AA, et al : Chemotherapy-induced peripheral neurotoxicity (CIPN) : An update. Crit Rev Oncol Hematol 82 : 51-77, 2012
PubMed
4) Argyriou AA, et al : Peripheral nerve damage associated with administration of taxanes in patients with cancer. Crit Rev Oncol Hematol 66 : 218-228, 2008
PubMed
5) Ravula SK, et al : Spatiotemporal localization of injury potentials in DRG neurons during vincristine-induced axonal degeneration. Neurosci Lett 415 : 34-39, 2007
PubMed
6) Argyriou AA, et al : Bortezomib-induced peripheral neuropathy in multiple myeloma : a comprehensive review of the literature. Blood 112 : 1593-1599, 2008
PubMed
7) Flatters SJ, et al : Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neurosci Lett 397 : 219-223, 2006
PubMed
8) Hayakawa K, et al : NGF prevention of neurotoxicity induced by cisplatin, vincristine and taxol depends on toxicity of each drug and NGF treatment schedule : in vitro study of adult rat sympathetic ganglion explants. Brain Res 794 : 313-319, 1998
PubMed
9) Ogura K, et al : Vinca alkaloids induce granulocyte-macrophage colony stimulating factor in human peripheral blood mononuclear cells. Anticancer Res 20 : 2383-2388, 2000
PubMed
10) Cata JP, et al : Cyclooxygenase inhibitors and thalidomide ameliorate vincristine-induced hyperalgesia in rats. Cancer Chemother Pharmacol 54 : 391-397, 2004
PubMed
11) Matsumoto M, et al : Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther 318 : 735-740, 2006
PubMed
12) Thibault K, et al : Serotonin 5-HT2A receptor involvement and Fos expression at the spinal level in vincristineinduced neuropathy in the rat. Pain 140 : 305-322, 2008
PubMed
13) Kautio AL, et al : Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Symptom Manage 35 : 31-39, 2008
PubMed
14) Hammack JE, et al : Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain 98 : 195-203, 2002
PubMed
15) Rao RD, et al : Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy : a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 110 : 2110-2118, 2007
PubMed
16) Saif MW, et al : Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy. Anticancer Res 30 : 2927-2933, 2010
PubMed
17) Lynch JJ 3rd, et al : Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model. Pain 110 : 56-63, 2004
 
18) Rao RD, et al : Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy : a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer 112 : 2802-2808, 2008
PubMed
19) Cata JP, et al : Mechanisms of chemotherapy-induced neuropathic pain. Cancer Pain : From Molecules to Suffering, Paice JA, et al eds, IASP press, Seattle, 3-26, 2010
 
20) Bianchi G, et al : Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine. Eur J Cancer 41 : 1746-1750, 2005
PubMed
21) 梶浦新也ほか : 抗がん剤誘発性末梢神経障害の薬物療法 (2) 漢方薬. ペインクリニック 31 : S287-S296, 2010
 
22) Stubblefield MD, et al : A prospective surveillance model for physical rehabilitation of women with breast cancer : chemotherapy-induced peripheral neuropathy. Cancer 118 : 2250-2260, 2012
PubMed
23) Smith EM, et al : Effect of duloxetine on pain, function, and quality of life among patients with chemotherapyinduced painful peripheral neuropathy : : a randomized clinical trial. JAMA 309 : 1359-1367, 2013
PubMed
P.264 掲載の参考文献
1) Kidd BL, et al : Mechanisms of inflammatory pain. Br J Anaesth 87 : 3-11, 2001
PubMed
2) Woolf CJ : What is this thing called pain? J Clin Invest 120 : 3742-3744, 2010
 
3) Burgess G, et al : The discovery and development of analgesics : new mechanisms, new modalities. J Clin Invest 120 : 3753-3759, 2010
PubMed
4) Ong CK, et al : An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res 5 : 19-34, 2007
 
5) Kuehn BM : FDA panel : keep COX-2 drugs on market : black box for COX-2 labels, caution urged for all NSAIDs. JAMA 293 : 1571-1572, 2005
PubMed
6) Hodgman MJ, et al : A review of acetaminophen poisoning. Crit Care Clin 28 : 499-516, 2012
PubMed
7) Scott DL : Biologics-based therapy for the treatment of rheumatoid arthritis. Clin Pharmacol Ther 91 : 30-43, 2012
PubMed
8) Oxford League Table of Analgesics in Acute Pain. Bandolier Web site. Available at : http://www.medicine.ox.ac.uk/bandolier/booth/painpag/Acutrev/Analgesics/lftab.html
 
9) Dhillon S : Tramadol/paracetamol fixed-dose combination : a review of its use in the management of moderate to severe pain. Clin Drug Investig 30 : 711-738, 2010
PubMed
10) Singh G, et al : Celecoxib versus naproxen and diclofenac in osteoarthritis patients : SUCCESS-I Study. Am J Med 119 : 255-266, 2006
PubMed
11) Towheed TE, et al : Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 25 : CD004257, 2006
 
P.268 掲載の参考文献
1) Johnson RW, et al : Prevention of herpes zoster pain. Pain Manage 2 : 63-69, 2012
 
2) Lilie HM, et al : The role of antivirals in the management of neuropathic pain in the older patient with herpes zoster. Drugs Aging 20 : 561-570, 2003
PubMed
3) Dworkin RH, et al : Recommendations for the management of herpes zoster. Clin Infect Dis 44 (suppl 1) : S1-S26, 2007
 
4) 山村秀夫ほか : ノイロトロピン錠の帯状疱疹後神経痛に対する効果 : プラセボ錠を対照薬とした多施設二重盲検試験. 医学のあゆみ 147 : 651-664, 1988
Medical*Online
5) Nurmikko T, et al : Somatosensory findings in postherpetic neuralgia. J Neurol Neurosurg Psychiatry 53 : 135-141, 1990
PubMed
6) Hempenstall K, et al : Analgesic therapy in postherpetic neuralgia : a quantitative systematic review. PLoS Med 2 : e164, 2005
PubMed
7) Attal N, et al : EFNS guidelines on neuropathic pain assessment : revised 2009. Eur J Neurol 17 : 1010-1018, 2010
PubMed
8) Nurmikko T, et al : Pain and allodynia in postherpetic neuralgia : role of somatic and sympathetic nervous systems. Acta Neurol Scand 84 : 146-152, 1991
PubMed
P.273 掲載の参考文献
1) Nikolajsen L : Postamputation pain : Studies on mechanisms. Dan Med J 59 : B4527 1-21, 2012
PubMed
2) Jensen TS, et al : Phantom limb pain and other phenomena after amputation. Textbook of Pain, Wall PD, et al eds, 4th ed, Churchill Livingstone, Edinburgh, 799-814, 1999
 
3) Wall PD, et al : Properties of afferent nerve impulses originating from a neuroma. Nature 248 : 740-743, 1974
PubMed
4) Flor H, et al : Phantom limb pain : a case of maladaptive CNS plasticity? Nat Rev Neurosci 7 : 873-881, 2006
PubMed
5) Roux FE, et al : Virtual movements activate primary sensorimotor areas in amputees : report of three cases. Neurosurgery 49 : 736-741, 2001
PubMed
6) Subedi B, et al : Phantom limb pain : mecahnisms and treatment approaches. Pain Res Treat 2011 : 864605, 2011
 
7) Alvir MJM, et al : Pharmacologic interventions for treating phantom limb pain (Review). Cochrane Database Sys Rev 12 : CD006380 : 1-54, 2012
 
8) Woolf A, et al : Evidence-based medicine. 21. Phantom pain. Pain Practice 11 : 403-413, 2011
 
9) Huse E, et al : The effect of opioids on phantom limb pain and cortical reorganization. Pain 90 : 47-55, 2001
PubMed
10) Wu CL, et al : Analgesic effects of intravenous lidocaine and morphine on postamputation pain. A randomized double-blind, active placebo-controlled, crossover trial. Anesthesiology 96 : 841-848, 2002
 
11) Wilder-Smith CH, et al : Postamputation pain and sensory change in treatment-naive patients. Characteristics nad responses to treatment with tramadol, amitriptyline, and placebo. Anesthesiology 103 : 619-628, 2005
 
12) Robinson LR, et al : Trial of amitriptyline for relief of pain in amputees : Results of a randomaized controlled study. Arch Phys Med Rehabil 81 : 1-6, 2004
 
13) Spiegel DR, et al : A presumed case of phantom limb pain treated successfully with duloxetine and pregabalin. Gen Hos Psychiatry 32 : 228e5-e7, 2010
 
14) Bone M, et al : Gabapentin in postamputation phantom limb pain : A randomized, double-blind, placebo-controlled, cross-over study. Reg Anesth Pain Med 27 : 481-486, 2002
PubMed
15) Nagoshi Y, et al : Usefulness of milnacipran in treating phantom limb pain. Neuropsychiatr Dis Treat 8 : 549-553, 2012
PubMed
16) Diers M, et al : Mirrored, imagined and executed movements differently activate sensorimotor cortex in amputees with and without phantom limb pain. Pain 149 : 296-304, 2010
 
P.278 掲載の参考文献
1) Hotta N, et al : Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy : the 3-year, multicenter, comparative aldose reductase inhibitor-diabetes complications trial. Diabetes Care 29 : 1538-1544, 2006
PubMed
2) Hotta N, et al : Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat. Diabet Med 25 : 818-825, 2008
PubMed
3) Ziegler D : Treatment of diabetic polyneuropathy update 2006. Ann NY Acad Sci 1084 : 250-266, 2006
PubMed
4) Yasuda H, et al : Superiority of duloxetine to placebo in improving diabetic neuropathic pain : Results of a randomized controlled trial in Japan. J Diabetes Invest 2 : 132-139, 2011
 
5) Rosenstock J, et al : Pregabalin for the treatment of painful diabetic peripheral neuropathy : a double-blind, placebocontrolled trial. Pain 110 : 628-638, 2004
PubMed
6) Satoh J, et al : Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy : a 14 week, randomized, double-blind, placebocontrolled trial. Diabet Med 28 : 109-116, 2011
PubMed
7) Bril V, et al : Evidence-based guideline : Treatment of painful diabetic neuropathy : Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 76 : 1758-1765, 2011
 
8) Dyck PJ, et al : Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies : new insights into pathophysiology and treatment. Muscle Nerve 25 : 477-491, 2002
PubMed
9) Tesfaye S, et al : Painful diabetic peripheral neuropathy : consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev 27 : 629-638, 2011
PubMed
10) 日本ペインクリニック学会 : 神経障害性疼痛薬物療法ガイドライン, 真興交易医書出版部, 東京, 1-50, 2011
 
P.283 掲載の参考文献
1) Janetta PJ : Arterial compression of the trigeminal nerve at the pons in patient with trigeminal neuralgia. J Neurosurg 26 : 1159-1162, 1967
 
2) McLaughlin MR, et al : Microvascular decompression of cranial nerves : lessons learned after 4400 operations. J Neurosurg 90 : 1-8, 1999
PubMed
3) Devor M, et al : Pathophysiology of trigeminal neuralgia : The ignition hypothesis. Clin J Pain 18 : 4-13, 2002
PubMed
4) Cheng TM, et al : Comprehensive study of diagnosis and treatment of trigeminal neuralgia secondary to tumors. Neurology 43 : 2298-2302, l993
 
5) Nurmikko TJ, et al : Trigeminal neuralgia-pathophysiology, diagnosis and current treatment. Br J Anaesth 87 : 117-132, 2001
PubMed
6) Pagni CA : The origin of tic douloureux : A unified view. J Neurosurg Sci 37 : 185-194, l993
 
7) Rappaport ZH, et al : Trigeminal neuralgia : The role of self-sustaining discharge in the trigeminal ganglion. Pain 56 : 127-138, 1994
 
8) Bouchelet I, et al : Differential expression of sumatriptansensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol Pharmacol 50 : 219-223, 1996
PubMed
9) Limmroth V, et al : An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system. Pain 92 : 101-106, 2001
 
10) Kanai A, et al : Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache 46 : 577-582, 2006
PubMed
11) Shimohata K, et al : Nasal sumatriptan as adjunctive therapy for idiopathic trigeminal neuralgia : report of three cases. Headache 49 : 768-770, 2009
PubMed
12) Moran J, et al : Treatment resistant trigeminal neuralgia relieved with oral sumatriptan : a case report. J Med Case Rep 3 : 7229, 2009
PubMed
P.286 掲載の参考文献
1) Starzi-Puttini P, et al : Chronic widespread pain : from peripheral to central evolution. Best Pract Res Clin Rheumatol 25 : 133, 2011
 
2) Schmidt-Wilcke T, et al : Fibromyalgia : from pathophysiology to therapy. Nat Rev Rheumatol 7 : 518, 2011
PubMed
3) Wolfe F, et al : The American College of Rheumatology 1990 criteria for the classification of fibromyalgia : report of the multicenter criteria committee. Arthritis Rheum 3 : 160-172, 1990
 
4) McBeth J, : Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol 21 : 403-425, 2007
PubMed
5) Wolfe F, et al : Fibromyalgia criteria and severity scales for clinical and epidemiological studies : a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 38 : 1113-1122, 2011
PubMed
6) Wolfe F, et al : The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Ar thritis Care Res (Hoboken) 62 : 600-610, 2010
 
7) Usui C, et al : The Japanese version of the 2010 American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and the Fibromyalgia Symptom Scale : reliability and validity. Mod Rheumatol 22 : 40-44, 2012
PubMed
8) Bellato E, et al : Fibromyalgia syndrome : etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat 2012 : 1-17, 2012
 
9) Price DD, et al : Neurobiology of fibromyalgia syndrome. J Rheumatol 32 : 22-28, 2005
 
10) Clauw DJ, et al : The science of fibromyalgia. Mayo Clin Proc 86 : 907-911, 2011
PubMed
11) Russell IJ, et al : Serum amino acids in fibrositis/fibromyalgia syndrome. J Rheumatol Suppl 19 : 158-163,1989
 
12) Vaeroy H, et al : Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia : new features for diagnosis. Pain 32 : 21-26, 1988
PubMed
13) Ruiz Moral R, et al : Biopsychosocial features of patients with widespread chronic musculoskeletal pain in family medicine clinic. Fam Pract 14 : 242-248, 1997
PubMed
14) Endresen GK : Fibromyalgia : a rheumatologic diagnosis? Rheumatol Int 27 : 999-1004, 2007
PubMed
15) Warren JW, et al : Functional somatic syndromes : sensitivities and specificities of self-reports of physician diagnosis. Psychosom Med 74 : 891-895, 2012
PubMed
16) Sarzi-Puttini P, et al : Multidisciplinary approach to fibromyalgia : what is the teaching? Best Pract Res Clin Rheumatol 25 : 311-319, 2011
PubMed
17) Hauser W, et al : Efficacy of multicomponent treatment in fibromyalgia syndrome : a meta-analysis of randomized controlled clinical trials. Arthritis Rheum 61 : 216-224, 2009
PubMed
18) Smith MT, et al : Pregabalin for the treatment of fibromyalgia. Expert Opin Pharmacother 13 : 1527-1533, 2012
PubMed
19) Crofford LJ, et al : Pregabalin for the treatment of fibromyalgia syndrome : results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52 : 1264-1273, 2005
PubMed
20) Arnold LM, et al : Gabapentin in the treatment of fibromyalgia : a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 256 : 1336-1344, 2007
 
21) Mease PJ, et al : Pharmacotherapy of fibromyalgia. Best Pract Res Clin Rheumatol 25 : 285-297, 2011. doi : 10.1016/j.berh.2011.01.015
 
22) Hauser W, et al : Guidelines on the management of fibromyalgia syndrome-a systematic review. Eur J Pain 14 : 5-10, 2010
PubMed
23) Arnold LM : Strategies for managing fibromyalgia. Am J Med 12 : S31-43, 2009
 
24) Friedberg F, et al : Lifestyle-oriented non-pharmacological treatments for fibromyalgia : a clinical overview and applications with home-based technologies. J Pain Res 5 : 425-435, 2012
 
25) Carville SF, et al : EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67 : 536-541, 2008
PubMed
26) Phillips K, et al : Central pain mechanisms in chronic pain states-maybe it is all in their head. Best Pract Res Clin Rheumatol 25 : 141-154, 2011
PubMed
27) Rivera J, et al : Drug prescription strategies in the treatment of patients with fibromyalgia. Reumatol Clin 8 : 184-188, 2012
PubMed
28) Rivera J, et al : Drug prescription strategies in the treatment of patients with fibromyalgia. Reumatol Clin 8 : 184-188, 2012
PubMed
29) Choy E, et al : A systematic review and mixed treatment comparison of the efficacy of pharmacological for fibromyalgia. Semin Arthritis Rheumm 41 : 335-345, 2011
PubMed
30) O'Malley PG, et al : Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 48 : 980-990, 1999
PubMed
31) Wolfe F, et al : A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 23 : 255-259, 1994
 
32) Di Franco M, et al : Pharmacological treatment of fibromyalgia. Clin Exp Rheumatol 28 : S110-116, 2010
PubMed
33) Staud R, et al : Effects of the N-methyl-D-aspartate receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects. J Pain 6 : 323-332, 2005
 
34) Bennett R : Fibromyalgia, chronic fatigue syndrome, and myofascial pain. Curr Opin Rheumatol 10 : 95-103, 1998
PubMed
35) See S, et al : Choosing a skeletal muscle relaxant. Am Fam Physician 78 : 365-370, 2008
PubMed
36) Han C, et al : Available therapies and current management of fibromyalgia : focusing on pharmacological agents. Drugs Today 47 : 539-557, 2011
PubMed
37) Sarzi-Puttini P, et al ; Italian Fibromyalgia Network : Fibromyalgia syndrome : the pharmacological treatment options. Reumatismo 60 (suppl 1) : 50-58, 2008
 
38) Thieme K, et al : Responder criteria for operant and cognitive-behavioral treatment of fibromyalgia syndrome. Arthritis Rheum 57 : 830-836, 2007
PubMed
39) Castel A, et al : Effect of hypnotic suggestion on fibromyalgic pain : comparison between hypnosis and relaxation. Eur J Pain 11 : 463-468, 2007
PubMed
P.294 掲載の参考文献
1) Schott GD : Pain and the sympathetic nervous system. Autonomic Failure, Mathias CJ, et al eds, 4th ed, Oxford University Press, Oxford, 520-526, 1999
 
2) Sumitani M, et al : Development of comprehensive diagnostic criteria for complex regional pain syndrome in the Japanese population. Pain 150 : 243-249, 2010
PubMed
3) Stanton-Hicks MD, et al : An update interdisciplinary clinical pathway for CRPS : Report of and expert panel. Pain Practice 2 : 1-16, 2002
 
4) Jensen TS : Neuropathic pain : definition and screening. Eur J Pain 11 : S7-8, 2007
 
5) Treede RD, et al : Neuropathic pain : Redefinition and a grading system for clinical and research purposes. Neurology 70 : 1630-1635, 2008
 
6) Azari P, et al : Efficacy and safety of ketamine in patients with complex regional pain syndrome : a systematic review. CNS Drugs 26 : 215-228, 2012
PubMed
P.300 掲載の参考文献
1) Langford LA, et al : Afferent and efferent axons in the medial and posterior articular nerves of the cat. Anat Rec 206 : 71-78, 1983
PubMed
2) Schaible HG, et al : Update on peripheral mechanisms of pain : beyond prostaglandins and cytokines. Arthritis Res Ther 13 : 210, 2011
PubMed
3) Ikeuchi M, et al : Role of ASIC3 in the primary and secondary hyperalgesia produced by joint inflammation in mice. Pain 137 : 662-669, 2008
PubMed
4) Ikeuchi M, et al : Acid-sensing ion channel 3 expression in mouse knee joint afferents and effects of carrageenaninduced arthritis. J Pain 10 : 336-342, 2009
PubMed
5) Izumi M, et al : Local ASIC3 modulates pain and disease progression in a rat model of osteoarthritis. J Biomed Sci 19 : 77, 2012
 
6) McDougall JJ : Arthritis and pain. Neurogenic origin of joint pain. Arthritis Res Ther 8 : 220, 2006
PubMed
7) Schaible HG, et al : Pathophysiology and treatment of pain in joint disease. Adv Drug Deliv Rev 58 : 323-342, 2006
PubMed
8) Woolf CJ : Central sensitization : implications for the diagnosis and treatment of pain. Pain 152 : S2-15, 2011
PubMed
9) Hochman JR, et al : The ner ve of osteoar thritis pain. Arthritis Care Res (Hoboken) 62 : 1019-1023, 2010
 
10) 泉仁ほか : 整形外科入院患者における神経障害性疼痛の頻度 : スクリーニングツールを用いた横断的調査. 整形外科 63 : 931-933, 2012
 
11) Ushida T, et al : Changes in dorsal horn neuronal responses in an experimental wrist contracture model. J Orthop Sci 6 : 46-52, 2001
 
12) Nishigami T, et al : Changes in calcitonin gene-related peptide expression following joint immobilization in rats. Neurosci Lett 454 : 97-100, 2009
PubMed
13) 池内昌彦ほか : 内側型変形性膝関節症の疼痛の検討. JOSKAS 35 : 132-133, 2010
Medical*Online
14) Mense S : Referral of muscle pain : new aspects. Am Pain Soc J 3 : 1-9, 1994
 
15) 川田倫子ほか : 股関節疾患における関連痛に関する臨床的検討. Pain Res 21 : 127-132, 2006
Medical*Online
16) Bjordal JM, et al : Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain : meta-analysis of randomised placebo controlled trials. BMJ 329 : 1317, 2004
PubMed
17) Chou R, et al : Comparative effectiveness and safety of analgesics for osteoarthritis : comparative effectiveness review. Agency for Healthcare Research and Quality, 2006
PubMed
18) Chen YF, et al : Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoar thritis and rheumatoid ar thritis : a systematic review and economic evaluation. Health Technol Assess 12 (11) : 1-278, iii, 2008
 
19) Masso Gonzalez EL, et al : Variability among nonsteroidal anti-inflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum 62 : 1592-1601, 2010
PubMed
20) Warner TD, et al : COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs. Lancet 371 : 270-273, 2008
 
21) Trelle S, et al : Cardiovascular safety of non-steroidal anti-inflammatory drugs : network meta-analysis. BMJ 342 : c7086, 2011
PubMed
22) Derry S, et al : Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev 9 : CD007400, 2012
 
23) Towheed TE, et al : Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 1 : CD004257, 2006
PubMed
24) Zhang W, et al : OARSI recommendations for the management of hip and knee osteoar thritis, part I : critical appraisal of existing treatment guidelines and systematic review of cur rent research evidence. Osteoar thritis Cartilage 15 : 981-1000, 2007
 
25) Gotzsche PC, et al : Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Cochrane Database Syst Rev 3 : CD000189, 2004
PubMed
26) Kirwan JR : The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med 333 : 142-146, 1995
 
27) Wallen M, et al : Intra-articular steroids and splints/rest for children with juvenile idiopathic arthritis and adults with rheumatoid arthritis. Cochrane Database Syst Rev 1 : CD002824, 2006
PubMed
28) Bellamy N, et al : Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2 : CD005328, 2006
PubMed
29) Gomis A, et al : Nociceptive nerve activity in an experimental model of knee joint osteoarthritis of the guinea pig : effect of intra-articular hyaluronan application. Pain 130 : 126-136, 2007
 
30) Cheng OT, et al : Evidence-based knee injections for the management of arthritis. Pain Med 13 : 740-753, 2012
PubMed
31) Saito S, et al : Is there evidence in support of the use of intra-articular hyaluronate in treating rheumatoid arthritis of the knee? A meta-analysis of the published literature. Mod Rheumatol 19 : 493-501, 2009
 
32) Reichenbach S, et al : Hylan versus hyaluronic acid for osteoarthritis of the knee : a systematic review and metaanalysis. Arthritis Rheum 57 : 1410-1418, 2007
PubMed
33) Avouac J, et al : Efficacy and safety of opioids for osteoarthritis : a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 15 : 957-965, 2007
PubMed
34) Whittle SL, et al : Opioid therapy for treating rheumatoid arthritis pain. Cochrane Database Syst Rev 11 : CD003113, 2011
PubMed
35) Zhang W, et al : OARSI recommendations for the management of hip and knee osteoarthritis : part III : Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 18 : 476-499, 2010
PubMed
36) Wandel S, et al : Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee : network meta-analysis. BMJ 341 : c4675, 2010
 
37) Smolen JS, et al : EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 69 : 964-975, 2010
PubMed
P.305 掲載の参考文献
1) 厚生労働省 : 国民生活基礎調査 http://www.mhlw.go.jp
 
2) Nakamura M, et al : Prevalence and characteristics of chronic musculoskeletal pain in Japan. J Orthop sci 16 : 424-432, 2011
PubMed
3) Willis WD, et al : Sensory Mechanisms of the Spinal Cord. Plenum Press, New York and London, 1991
 
4) Lund JP, et al : The pain-adaptation model ; a discussion of the relationship between chronic musculoskeletal pain and motor activity. Can J Physiol Pharmacol 69 : 683-694, 1991
 
5) 仙波恵美子 : 筋骨格系の痛み?その慢性化のメカニズム. 臨整外 46 : 291-302, 2011
 
6) Franzini-Armstrong E : Myology, 3rd ed. McGraw-Hill, New York, 1739-1753, 1994
 
7) 青木吉嗣ほか : 筋痛の診断と治療. MB Orthop 24 : 143-152, 2011
 
8) 青木吉嗣 : 筋の慢性痛の機序. 整形外科 63 : 761-766, 2012
 
9) 水村和枝 : 筋・筋膜の痛み. Practice of Pain Management 3 : 104-109, 2012
 
10) Kumazawa T, et al : Thin-fibre receptors responding to mechanical, chemical, and thermal stimulation in the skeletal muscle of the dog. J Physiol 273 : 179-194, 1977
PubMed
11) 熊澤孝朗 : 慢性痛症のメカニズム. 理療ジャーナル 42 : 87-94, 2008
 
12) 井上真輔ほか : 運動器慢性痛の病態と学際的治療. BRAIN and NERVE 64 : 1287-1297, 2012
 
13) 牛田享宏 : 運動器の痛みのメカニズムと課題. 現代医学 58 : 213-219, 2010
Medical*Online
14) 牛田享宏 : 運動器慢性痛と学際的アプローチ. 理学療法学 38 : 649-652, 2011
Medical*Online
P.310 掲載の参考文献
1) 高橋弦ほか : 椎間板性腰痛の基礎. 日腰痛会誌 13 : 10-16, 2007
Medical*Online
2) Shinohara H : Lumbar disc lesion, with special reference to the histological significance of nerve endings of the lumbar discs. J Jpn Orthop Assoc 44 : 553-570, 1970
 
3) Burke JG, et al : Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br 84 : 196-201, 2002
PubMed
4) Karppinen J, et al : Is the interleukin-6 haplotype a prognostic factor for sciatica? Eur J Pain 12 : 1018-1025, 2008
PubMed
5) 腰痛診療ガイドライン 2012, 日本整形外科学会/日本腰痛学会監修, 日本整形外科学会診療ガイドライン委員会/腰痛診療ガイドライン策定委員会編, 南江堂, 東京, 40-45, 2012
 
6) 河合眞一 : NSAIDsの歴史 Q&A. 日本医学出版, 東京, 1-2, 2000
 
7) van tulder MW, et al : Non-steroidal anti-inflammatory drugs (NSAIDs) for non-specific low back pain. In : The Cochrane Library, Issue 4, 2001. Oxford : Update Software. Search date 1998 ; primary source Medline, Embase, Cochrane Controlled Trials Register, and hand searches of references
 
8) 日本クリニカルエビデンス委員会・監 : 腰痛および坐骨神経痛 (急性) (クリニカルエビデンスISSUE9日本語版), 日経BP社, 東京, 1372-1388, 2004
 
9) Bruggemann G, et al : Results of a double-blind study of diclofenac + vitamin B1, B6, B12 versus diclofenac in patients with acute pain of the lumbar vertebrae. A multicenter study. Klin Wochenschr 68 : 116-120, 1990
PubMed
10) Koes BW, et al : Epidural steroid injections for low back pain and sciatica : an update systematic review of randomized clinical trials. Pain Digest 9 : 241-247, 1999. Search date ; primary sources Medline and hand searches of relevant publications.
 
11) 高橋和久 : 第4章 腰痛の薬物療法に関するエビデンス 科学的根拠 (Evidence Based Medicine, EBM) に基づいた腰痛診療のガイドライン策定に関する研究, 厚生科研 (21世紀型医療開拓推進研究事業), 199-247, 2001
 
12) van Tulder MW, et al : Cochrane Back Review Group. Muscle relaxants for nonspecific low back pain : a systematic review within the framework of the cochrane collaboration. Spine 28 : 1978-1992. Review, 2003
PubMed
13) Cherkin DC, et al : Medication use for low back pain in primary care. Spine 23 : 607-614, 1998
PubMed
14) Coats TL, et al : Effects of valdecoxib in the treatment of chronic low back pain : results of a randomized, placebocontrolled trial. Clin Ther 26 : 1249-1260, 2004
PubMed
15) Birbara CA, et al : Etoricoxib Protocol 042 Study Group. Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor : improvement in pain and disability-a randomized, placebo-controlled, 3-month trial. J Pain 4 : 307-315, 2003
 
16) Fishbain D : Evidence-based data on pain relief with antidepressants Ann Med 32 : 305-316, 2000
PubMed
17) Galer BS, et al : Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain.Curr Med Res Opin 20 (suppl 2) : S5-12, 2004
 
18) Roy R, et al : Chronic pain and depression a review. Compr Psychiatry 25 : 96-105, 1984
PubMed
19) Nakao M, et al : Major depression and somatic symptoms in a mind/body medicine clinic. Psychopathology 34 : 230-235, 2001
 
20) Krishnan K : Chronic pain and depression in chronic low back pain patients. Pain 22 : 279, 1995
 
21) Atkinson JH, et al : Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain 83 : 137-145, 1999
PubMed
22) Ruoff GE, et al : Protocol CAPSS-112 Study Group. Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain : a multicenter, randomized, double-blind, placebo-controlled outpatient study. Clin Ther 25 : 1123-1141, 2003
 
23) Ohtori S, et al : Transdermal Fentanyl for Chronic Low Back Pain. Yonsei Med J 53 : 788-793, 2012
PubMed
24) Chou R, et al : Nonsurgical interventional therapies for low back pain : a review of the evidence for an American Pain Society clinical practice guideline. Spine (Phila Pa 1976) 34 : 1078-1093. Review, 2009
PubMed
25) Manchikanti L, et al : A Critical Review of the American Pain Society Clinical Practice Guidelines For Interventional Techniques : Part 2. Therapeutic Inter ventions. Pain Physician 13 : E215-E264・ISSN 2150-1149, 2010
 
26) Lane NE, et al : Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med 363 : 1521-1531, 2010
PubMed
27) Tobinick EL, et al : Peridiscal TNF-alpha inhibition for discogenic pain. Swiss Medical Weekly 133 : 170-177, 2003
 
28) Cohen SP, et al : A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy. Anesthesiology 107 : 99-105, 2007
PubMed
29) Korhonen T et al : Efficacy of infliximab for disc herniation-induced sciatica : one-year follow-up. Spine 29 : 2115-2119, 2004
PubMed
30) Korhonen T, et al : The treatment of disc herniationinduced sciatica with infliximab : results of a randomized, controlled, 3-month follow-up study. Spine 30 : 2724-2728, 2005
PubMed
31) Cohen SP, et al : Randomized, double-blind, placebo-controlled, dose-response, and preclinical safety study of transforaminal epidural etanercept for the treatment of sciatica. Anesthesiology 110 : 1116-1126, 2009
PubMed
32) Ohtori S, et al : Epidural administration of spinal nerves with the tumor necrosis factor-alpha inhibitor, etanercept, compared with dexamethasone for treatment of sciatica in patients with lumbar spinal stenosis : A Prospective Randomized Study. Spine 37 : 439-444, 2012
PubMed
33) Ohtori S, et al : Efficacy of epidural administration of antiinterleukin-6 receptor antibody onto spinal nerve for treatment of sciatica. Eur Spine J 21 : 2079-2084, 2012
 
P.313 掲載の参考文献
1) Xie W, et al : Neuropathic pain : early spontaneous afferent activity is the trigger. Pain 116 : 243-256, 2005
PubMed
2) Wehnert Y, et al : Sympathetically maintained pain (SMP) : phentolamine test vs sympathetic ner ve blockade. Comparison of two diagnostic methods. Orthopade 31 : 1076-1083, 2002
 
3) 橋本篤ほか : 末梢神経ブロックに関連する合併症報告. 麻酔 60 : 111-119, 2011
Medical*Online
4) 藤本寛子ほか : 超音波ガイド下閉鎖神経ブロックで内転筋群血腫を生じた一症例. 日臨麻会誌 32 : S219, 2012
Medical*Online
5) 奥田泰久 : 日本ペインクリニック学会治療指針. 日臨麻会誌 32 : 488-493, 2012
Medical*Online
P.315 掲載の参考文献
1) 厚生労働省 : 今後の慢性の痛み対策について (提言), 2010
 
2) 日本整形外科学会・日本腰痛学会 : 腰痛診療ガイドライン, 2012
 
3) Sibon I, et al : Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology 62 : 1187-1189, 2004
PubMed
4) Maulaz AB, et al : Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol 62 : 1217-1220, 2005
 
5) 日本消化器内視鏡学会 : 抗血栓薬服用者に対する消化器内視鏡診療ガイドライン, 2012
Medical*Online

書評

最近チェックした商品履歴

Loading...